神経・精神疾患による消化管障害ベッドサイドマニュアル

出版社： 中外医学社
発行日： 2019-03-05
分野： 臨床医学：内科  >  脳神経科学/神経内科学
ISBN： 9784498140486
電子書籍版： 2019-03-05 （1版1刷）
書籍・雑誌
≪全国送料無料でお届け≫
取寄せ目安：8～14営業日

7,040 円(税込)

購入する
電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

7,040 円(税込)

購入する

商品紹介

神経・精神疾患による消化管・排尿機能障害診療のバイブルが誕生！　総論では消化管・排尿機能と脳・脊髄・末梢神経との関係をわかりやすくまとめ，機能検査も含め，実践的な診断・治療のノウハウを解説．また各論では多岐にわたる神経疾患を網羅し，それぞれに伴う消化管障害について端的に記載した．脳腸連関・腸内細菌叢などに関する記述も充実！

目次

  • I　総論
    　1・消化器症状の背後にあるもの
    　2・特徴的な消化器症状群
    　3・症状をとらえるための機能検査
    　4・鑑別疾患
    　5・神経因性消化管機能障害の治療

    II　各論
    　1・脳疾患
    　1．脳血管障害　〈舘野冬樹　榊原隆次〉
    　2・脊髄疾患
    　3・末梢神経疾患（ニューロパチー）
    　4・筋疾患（ミオパチー）など
    　5・その他

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

I 総論

P.9 掲載の参考文献
1) de Groat WC. Integrative control of the lower urinary tract : preclinical perspective. Brit J Pharm. 2006 ; 147 : S25-40.
 
2) Fowler CJ, Griffiths DJ. A decade of functional brain imaging applied to bladder control. Neurourol Urodyn. 2010 ; 29 : 49-55.
PubMed
3) Ogawa T, Sakakibara R, Kuno S, et al. Prevalence and treatment of LUTS in patients with Parkinson disease or multiple system atrophy. Nature Revue Urology. 2017 ; 14 : 79-89.
PubMed
4) 榊原隆次, 編. 神経因性膀胱ベッドサイドマニュアル. 東京 : 中外医学社 ; 2014.
 
5) Drake MJ, Apostolidis A, Cocci A, et al. Neurogenic lower urinary tract dysfunction : Clinical management recommendations of the Neurologic Incontinence committee of the fifth International Consultation on Incontinence 2013. Neurourol Urodyn. 2016 ; 35 : 657-65.
PubMed
6) Sakakibara R, Kishi M, Ogawa E et al. Bladder, bowel, and sexual dysfunction in Parkinson's disease. Parkinsons Dis. 2011 ; 2011 : 924605. doi : 10.4061/2011/924605. Epub 2011 Sep 12.
 
7) 山名哲郎, 岩垂純一. 便失禁患者の病態と直腸肛門機能検査. 消化器科. 2000 ; 31 : 351-8.
 
8) 榊原隆次, 岸雅彦, 内山智之, 他. 定量的排便機能検査 (キューエルガット). 自律神経. 2009 ; 46 : 466-9.
 
9) Yamamoto T, Sakakibara R, Uchiyama T, et al. When is Onuf's nucleus involved in multiple system atrophy? A sphincter electromyography study. J Neurol Neurosurg Psychiatry. 2005 ; 76 : 1645-58.
PubMed
10) Ito T, Sakakibara R, Sakakibara Y, et al. Medulla and gut. Intern Med. 2004 ; 43 : 1091.
PubMed
11) Tateno F, Sakakibara R, Kishi M, et al. Brainstem stroke and increased anal tone. Low Urin Tract Symptoms. 2012 ; 4 : 161-3.
PubMed
12) Lynch AC, Anthony A, Dobbs BR, et al. Anorectal physiology following spinal cord injury. Spinal Cord. 2000 ; 38 : 573-80.
PubMed
13) Sakakibara R, Kishi M, Ogawa E, et al. Multiple-system atrophy presenting with low rectal compliance and bowel pain. Mov Disord. 2010 ; 25 : 1516-8.
PubMed
14) Sakakibara R, Ito T, et al. Depression, Anxiety and the Bladder. Low Urin Tract Symptoms. 2013 ; 5 : 109-20.
PubMed
15) Pecina M, Bohnert AS, Sikora M, et al. Association between placebo-activated neural systems and antidepressant responses : neurochemistry of placebo effects in major depression. JAMA Psychiatry. 2015 ; 72 : 1087-94.
PubMed
16) Orand A, Naliboff B, Gadd M, et al. Corticotropin-releasing hormone receptor 1 (CRH-R1) polymorphisms are associated with irritable bowel syndrome and acoustic startle response. Psychoneuroendocrinology. 2016 ; 73 : 133-41.
PubMed
17) Block TS, Kushner H, Kalin N, et al. Combined analysis of mifepristone for psychotic depression : plasma levels associated with clinical Response. Biol Psychiatry. 2018 ; 84 : 46-54.
PubMed
18) Chen Z, Venkat P, Seyfried D, et al. Brain-heart interaction : cardiac complications after stroke. Circ Res. 2017 ; 121 : 451-68.
PubMed
P.13 掲載の参考文献
1) Chapple CR, Khullar V, Gabriel Z, et al. The effects of antimuscarinic treatments in overactive bladder : an update of a systematic review and meta-analysis. Eur Urol. 2008 : 54 : 543-62.
PubMed
2) Moller LA, Lose G, Jorgensen T. Risk factors for lower urinary tract symptoms in women 40 to 60 years of age. Obstet Gynecol. 2000 ; 96 : 446-51.
 
3) Charach G, Greenstein A, Rabinovich P, et al. Alleviating constipation in the elderly improves lower urinary tract symptoms. Gerontology. 2001 ; 47 : 72-6.
PubMed
4) Monga AK, Marrero JM, Stanton SL, et al. Is there an irritable bladder in the irritable bowel syndrome? Br J Obstet Gynaecol. 1997 ; 104 : 1409-12.
PubMed
5) Inan M, Tokuc B, Aydiner CY, et al. Personal characteristics of enuretic children : an epidemiological study from South-East Europe. Urol Int. 2008 ; 81 : 47-53.
 
6) Loening-Baucke V. Urinary incontinence and urinary tract infection and their resolution with treatment of chronic constipation of childhood. Pediatrics. 1997 ; 100 : 228-32.
PubMed
7) Handa VL, Harris TA, Ostergard DR. Protecting the pelvic floor : obstetric management to prevent incontinence and pelvic organ prolapse. Obstet Gynecol. 1996 ; 88 : 470-8.
PubMed
8) Spence-Jones C, Kamm MA, Henry MM, et al. Bowel dysfunction : a pathogenic factor in uterovaginal prolapse and urinary stress incontinence. Br J Obstet Gynaecol. 1994 ; 101 : 147-52.
PubMed
9) Jackson SL, Weber AM, Hull TL, et al. Fecal incontinence in women with urinary incontinence and pelvic organ prolapse. Obstet Gynecol. 1997 ; 89 : 423-7.
PubMed
P.25 掲載の参考文献
1) Lacy BE, Mearin F, Chang L, et al. Bowel disorders. Gastroenterology. 2016 ; 150 : 1393-407.
 
2) Fukudo S, Kaneko H, Akiho H, et al. Evidence-based clinical practice guidelines for irritable bowel syndrome. J Gastroenterol. 2015 ; 50 : 11-30.
PubMed
3) Sperber AD, Dumitrascu D, Fukudo S, et al. The global prevalence of IBS in adults remains elusive due to the heterogeneity of studies : a Rome Foundation working team literature review. Gut. 2017 ; 66 : 1075-82.
 
4) Enck P, Aziz Q, Barbara G, et al. Irritable bowel syndrome (IBS). Nat Rev Dis Primers. 2016 ; 2 : 16014.
PubMed
5) Fukudo S. IBS : Autonomic dysregulation in IBS. Nat Rev Gastroenterol Hepatol. 2013 ; 10 : 569-71.
PubMed
6) Aizawa E, Sato Y, Kochiyama T, et al. Altered cognitive function of prefrontal cortex during error feedback in patients with irritable bowel syndrome, based on fMRI and dynamic causal modeling. Gastroenterology. 2012 ; 143 : 1188-98.
PubMed
7) Tana C, Umesaki Y, Imaoka A, et al. Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterol Motil. 2010 ; 22 : 512-9.
PubMed
8) Fukudo S, Kinoshita Y, Okumura T, et al. Ramosetron reduces symptoms of irritable bowel syndrome with diarrhea and improves quality of life in women. Gastroenterology. 2016 ; 150 : 358-66. e8.
 
9) Fukudo S, Hongo M, Kaneko H, et al. Lubiprostone increases spontaneous bowel movement frequency and quality of life in patients with chronic idiopathic constipation. Clin Gastroenterol Hepatol. 2015 ; 13 : 249-301. e5.
 
10) Fukudo S, Endo Y, Hongo M, et al ; Mizagliflozin Study Group. Safety and efficacy of the sodium-glucose cotransporter 1 inhibitor mizagliflozin for functional constipation : a randomised, placebo-controlled, double-blind phase 2 trial. Lancet Gastroenterol Hepatol. 2018 ; 3 : 603-13.
 
11) American Psychiatric Association : Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Washington DC : American Psychiatric Association ; 2013.
 
12) 日本心身医学会用語委員会, 編. 心身医学用語事典. 東京 : 医学書院 ; 1999.
 
13) Drossman DA. Rome IV-functional GI disorders : disorders of gut-brain interaction. Gastroenterology. 2016 ; 150 : 1257-61.
PubMed
14) Evidence-Based Medicine Working Group. Evidence-based medicine : a new approach to teaching the practice of medicine. JAMA. 1992 ; 268 : 2420-5.
 
15) Guthrie E, Creed F, Dawson D, et al. A controlled trial of psychological treatment for the irritable bowel syndrome. Gastroenterology. 1991 ; 100 ; 450-7.
 
16) Lackner JM, Jaccard J, Keefer L, et al. Improvement in gastrointestinal symptoms after cognitive behavior therapy for refractory irritable bowel syndrome. Gastroenterology. 2018 ; 155 : 47-57.
PubMed
P.58 掲載の参考文献
1) 大地陸男. 消化と吸収. In : 生理学テキスト. 第8版. 東京 : 文光堂 ; 2017. p.363-93.
 
2) 消化と吸収. In : 本間研一, 大森治紀, 大橋俊夫, 他. 標準生理学. 第8版. 東京 : 医学書院 ; 2014. p.795-842.
 
3) 朝倉均, 監修. 消化管・腹壁・腹膜疾患. In : 岡庭豊, 編. イヤーノート 2018 内科・外科編. 東京 : メディックメディア ; 2017. p.A2-16.
 
4) Hall JE. General principles of gastrointestinal function-motility, nervous control, and blood circulation. UNIT XII Gastrointestinal physiology. In : Guyton and Hall textbook of medical physiology. 13 th ed. Philadelphia : Elsevier ; 2016. p.797-806.
 
5) 福本陽平, 監修, 松村讓兒, 解剖監修, 解剖. 消化管総論. In : 医療情報科学研究所, 編. 病気がみえる vol. 1 消化器. 第5版. 東京 : メディックメディア ; 2016. p.2-7.
 
6) Barrett KE, Barman SM, Boitano S, et al. Gastrointestinal motility. gastrointestinal physiology. In : Ganong's review of medical physiology. 25th ed. New York : McGraw-Hill Education ; 2015. p.495-505.
 
7) 福本陽平, 監修. 生理. 消化管総論. In : 医療情報科学研究所, 編. 病院がみえる vol.1 消化器. 第5版. 東京 : メディックメディア ; 2016. p.10-15.
 
8) Barrett KE, Barman SM, Boitano S, et al. Overview of Gastrointestinal function & regulation. Gastrointestinal physiology. In : Ganong's review of medical physiology. 25th ed. New York : McGraw-Hill Education ; 2015. p.455.
 
9) Hall JE. Secretory functions of the alimentary tract. UNIT VII Gastrointestinal physiology. In : Guyton and Hall textbook of medical physiology. 13th ed. philadelphia : Elsevier ; 2016. p.817-32.
 
P.67 掲載の参考文献
1) 安原一, 監修. 新薬理学. 東京 : 日本医事新報社 ; 2015. p.151-9.
 
2) 丸山敬. これならわかる薬理学. 東京 : ナツメ社 ; 2016. p.64-80.
 
3) 今井正, 宮本英七, 監修. 飯野正光, 鈴木秀典, 編集. 標準薬理学. 東京 : 医学書院 ; 2015. p.535-51.
 
P.76 掲載の参考文献
1) Turnbaugh PJ, Ley RE, Mahowald MA, et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006 ; 444 : 1027-31.
PubMed
2) Collins SM, Bercik P. The relationship between intestinal microbiota and the central nervous system in normal gastrointestinal function and disease. Gastroenterology. 2009 ; 136 : 2003-14.
PubMed
3) Enck P, Aziz Q, Barbara G, et al. Irritable bowel syndrome. Nat Rev Dis Primers. 2016 ; 2 : 16014.
PubMed
4) Spiller RC, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology. 2009 ; 136 : 1979-88.
 
5) Simren M, Barbara G, Flint HJ, et al. Intestinal microbiota in functional bowel disorders : a Rome foundation report. Gut. 2013 ; 62 : 159-76.
PubMed
6) Jeffery IB, O'Toole PW, Ohman L, et al. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut. 2011 ; 61 : 997-1006.
PubMed
7) Tap J, Derrien M, Tornblom H, et al. Identification of an intestinal microbiota signature associated with severity of irritable bowel syndrome. Gastroenterology. 2017 ; 152 : 111-23.
PubMed
8) Malinen E, Krogius-Kurikka L, Lyra A, et al. Association of symptoms with gastrointestinal microbiota in irritable bowel syndrome. World J Gastroenterol. 2010 ; 16 : 4532-40.
PubMed
9) Jalanka-Tuovinen J, Salojarvi J, Salonen A, et al. Faecal microbiota composition and host-microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome. Gut. 2013 ; 63 : 1737-45.
PubMed
10) Tana C, Umesaki Y, Imaoka A, et al. Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterol Motil. 2010 ; 22 : 512-9.
PubMed
11) Tooth D, Garsed K, Singh G, et al. Characterisation of faecal protease activity in irritable bowel syndrome with diarrhoea : origin and effect of gut transit. Gut. 2014 ; 63 : 753-60.
PubMed
12) Gecse K, Roka R, Ferrier L, et al. Increased faecal serine protease activity in diarrhoeic IBS patients : a colonic lumenal factor impairing colonic permeability and sensitivity. Gut. 2008 ; 57 : 591-9.
PubMed
13) Carroll IM, Ringel-Kulka T, Ferrier L, et al. Fecal protease activity is associated with compositional alterations in the intestinal microbiota. PLoS One. 2013 ; 8 : e78017.
 
14) Schroeder FA, Lin CL, Crusio WE, et al. Antidepressant-like effects of the histone deacetylase inhibitor, sodium butyrate, in the mouse. Biol Psychiatry. 2007 ; 62 : 55-64.
PubMed
15) Clarke MB, Hughes DT, Zhu C, et al. The QseC sensor kinase : a bacterial adrenergic receptor. Proc Natl Acad Sci USA. 2006 ; 103 : 10420-5.
PubMed
16) Sudo N, Chida Y, Aiba Y, et al. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol. 2004 ; 558 : 263-75.
PubMed
17) Staudacher H, Lomer MCE, Anderson J, et al. Fermentable carbohydrate restriction reduces luminal bifidobacteria and gastrointestinal symptoms in patients with irritable bowel syndrome. J Nutr. 2012 ; 142 : 1510-8.
PubMed
18) Halmos EP, Christophersen CT, Bird AR, et al. Diets that differ in their FODMAP content alter the colonic luminal microenvironment. Gut. 2015 ; 64 : 93-100.
PubMed
19) Ford AC, Quigley EM, Lacy BE, et al. Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation : systematic review and meta-analysis. Am J Gastroenterol. 2014 ; 109 : 1547-61.
PubMed
20) Pinto-Sanchez MI, Hall GB, Ghajar K, et al. Probiotic Bifidobacterium longum NCC3001 reduces depression scores and alters brain activity : A pilot study in patients with irritable bowel syndrome. Gastroenterology. 2017 ; 153 : 448-59.
PubMed
21) 日本消化器病学会, 編. 機能性消化管疾患診療ガイドライン 2014-過敏性腸症候群 (IBS). 東京 : 南江堂 ; 2014.
 
22) Pimentel M, Lembo A, Chey WD, et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med. 2011 ; 364 : 22-32.
PubMed
23) Xu D, Gao J, Gillilland M 3rd, et al. Refaximin alters intestinal bacteria and prevents stress-induced gut inflammation and visceral hyperalgesia in rats. Gastroenterology. 2014 ; 146 : 484-96.
 
24) Rossen NG, MacDonald JK, de Vries EM, et al. Fecal microbiota transplantation as novel therapy in gastroenterology : A systematic review. World J Gastroenterol. 2015 ; 21 : 5359-71.
PubMed
25) Johnsen PH, Hilpusch F, Cavanagh JP, et al. Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome : a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial. Lancet Gastroenterol Hepatol. 2018 ; 3 : 17-24.
PubMed
P.88 掲載の参考文献
1) Chaudhuri KR, Schapira AH. Non-motor symptoms of Parkinson's disease : dopaminergic pathophysiology and treatment. Lancet Neurol. 2009 ; 8 : 464-74.
PubMed
2) Sakakibara R, Uchiyama T, Yamanishi T, et al. Bladder and bowel dysfunction in Parkinson's disease. J Neural Transm. 2008 ; 115 : 443-60.
PubMed
3) Uchiyama T, Sakakibara R, Yamamoto T, et al. Urinary dysfunction in early and untreated Parkinson's disease. J Neurol Neurosurg Psychiatry. 2011 ; 82 : 1382-6.
PubMed
4) Fukuyama H, Matsuzaki S, Ouchi Y, et al. Neural control of micturition in man examined with single photon emission computed tomography using 99mTc-HMPAO. Neuroreport. 1996 ; 7 : 3009-12.
PubMed
5) Matsuura S, Kakizaki H, Mitsui T, et al. Human brain region response to distention or cold stimulation of the bladder : a positron emission tomography study. J Urol. 2002 ; 168 : 2035-9.
PubMed
6) DasGupta R, Kavia RB, Fowler CJ. Cerebral mechanisms and voiding function. BJU Int. 2007 ; 99 : 731-4.
PubMed
7) Fowler CJ, Griffiths DJ. A decade of functional brain imaging applied to bladder control. Neurourol Urodyn. 2010 ; 29 : 49-55.
PubMed
8) Sakakibara R, Tateno F, Kishi M, et al. Pathophysiology of bladder dysfunction in Parkinson's disease. Neurobiol Dis. 2012 ; 46 : 565-71.
PubMed
9) Kitta T, Kakizaki H, Furuno T, et al. Brain activation during detrusor overactivity in patients with Parkinson's disease : a positron emission tomography study. J Urol. 2006 ; 175 : 994-8.
PubMed
10) Griffiths D, Tadic SD, Schaefer W, et al. Cerebral control of the bladder in normal and urge-incontinent women. Neuroimage. 2007 ; 37 : 1-7.
PubMed
P.94 掲載の参考文献
1) Fadgyas-Stanculete M, Buga AM, Popa-Wagner A, et al. The relationship between irritable bowel syndrome and psychiatric disorders : from molecular changes to clinical manifestations. J Mol Psychiatry. 2014 ; 2 : 4.
 
2) Keightley PC, Koloski NA, Talley NJ. Pathways in gut-brain communication : evidence for distinct gut-to-brain and brain-to-gut syndromes. Aust N Z J Psychiatry. 2015 ; 49 : 207-14.
PubMed
3) Koloski NA, Jones M, Kalantar J, et al. The brain--gut pathway in functional gastrointestinal disorders is bidirectional : a 12-year prospective population-based study. Gut. 2012 ; 61 : 1284-90.
PubMed
4) Chang L. The role of stress on physiologic responses and clinical symptoms in irritable bowel syndrome. Gastroenterology. 2011 ; 140 : 761-5.
PubMed
5) Dinan TG, Quigley EM, Ahmed SM, et al. Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome : plasma cytokines as a potential biomarker? Gastroenterology. 2006 ; 130 : 304-11.
PubMed
6) Stengel A, Tache Y. Corticotropin-releasing factor signaling and visceral response to stress. Exp Biol Med. 2010 ; 235 : 1168-78.
PubMed
7) Fukudo S, Nomura T, Hongo M. Impact of corticotropin-releasing hormone on gastrointestinal motility and adrenocorticotropic hormone in normal controls and patients with irritable bowel syndrome. Gut. 1998 ; 42 : 845-9.
PubMed
8) Kano M, Muratsubaki T, Van Oudenhove L, et al. Altered brain and gut responses to corticotropin-releasing hormone (CRH) in patients with irritable bowel syndrome. Scientific reports. 2017 ; 7 : 12425.
PubMed
9) Mayer EA, Tillisch K, Gupta A. Gut/brain axis and the microbiota. Clin Invest. 2015 ; 125 : 926-38.
PubMed
10) Mayer EA, Labus JS, Tillisch K, et al. Towards a systems view of IBS. Nat Rev Gastroenterol Hepatol. 2015 ; 12 : 592-605.
PubMed
11) Ulrich-Lai YM, Herman JP. Neural regulation of endocrine and autonomic stress responses. Nat Rev Neurosci. 2009 ; 10 : 397-409.
PubMed
12) Bandelow B, Baldwin D, Abelli M, et al. Biological markers for anxiety disorders, OCD and PTSD-a consensus statement. Part I : Neuroimaging and genetics. World J Biol Psychiatry. 2016 ; 17 : 321-65.
PubMed
13) Cervenka S, Hedman E, Ikoma Y, et al. Changes in dopamine D2-receptor binding are associated to symptom reduction after psychotherapy in social anxiety disorder. Translational psychiatry. 2012 ; 2 : e120.
PubMed
14) Lanzenberger RR, Mitterhauser M, Spindelegger C, et al. Reduced serotonin-1A receptor binding in social anxiety disorder. Biological psychiatry. 2007 ; 61 : 1081-9.
PubMed
15) Lanzenberger R, Wadsak W, Spindelegger C, et al. Cortisol plasma levels in social anxiety disorder patients correlate with serotonin-1A receptor binding in limbic brain regions. Int J Neuropsychopharmacol. 2010 ; 13 : 1129-43.
PubMed
16) Warwick JM, Carey PD, Cassimjee N, et al. Dopamine transporter binding in social anxiety disorder : the effect of treatment with escitalopram. Metab Brain Dis. 2012 ; 27 : 151-8.
PubMed
17) Labuschagne I, Phan KL, Wood A, et al. Oxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorder. Neuropsychopharmacology. 2010 ; 35 : 2403-13.
PubMed
18) Dodhia S, Hosanagar A, Fitzgerald DA, et al. Modulation of resting-state amygdala-frontal functional connectivity by oxytocin in generalized social anxiety disorder. Neuropsychopharmacology. 2014 ; 39 : 2061-9.
PubMed
19) Gorka SM, Fitzgerald DA, Labuschagne I, et al. Oxytocin modulation of amygdala functional connectivity to fearful faces in generalized social anxiety disorder. Neuropsychopharmacology. 2015 ; 40 : 278-86.
PubMed
20) Karl A, Schaefer M, Malta LS, et al. A meta-analysis of structural brain abnormalities in PTSD. Neurosci Biobehav Rev. 2006 ; 30 : 1004-31.
 
21) Etkin A, Wager TD. Functional neuroimaging of anxiety : a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. Am J Psychiatry. 2007 ; 164 : 1476-88.
PubMed
22) Murrough JW, Huang Y, Hu J, et al. Reduced amygdala serotonin transporter binding in posttraumatic stress disorder. Biological psychiatry. 2011 ; 70 : 1033-8.
 
23) Bonne O, Bain E, Neumeister A, et al. No change in serotonin type 1A receptor binding in patients with posttraumatic stress disorder. Am J Psychiatry. 2005 ; 162 : 383-5.
PubMed
24) Sullivan GM, Ogden RT, Huang YY, et al. Higher in vivo serotonin-1a binding in posttraumatic stress disorder : a PET study with [11C] WAY-100635. Depress Anxiety. 2013 ; 30 : 197-206.
PubMed
25) Murrough JW, Neumeister A. The serotonin 1B receptor : a new target for depression therapeutics? Biological Psychiatry. 2011 ; 69 : 714-5.
PubMed
26) Bremner JD, Innis RB, Southwick SM, et al. Decreased benzodiazepine receptor binding in prefrontal cortex in combat-related posttraumatic stress disorder. Am J Psychiatry. 2000 ; 157 : 1120-6.
PubMed
27) Price JL, Drevets WC. Neural circuits underlying the pathophysiology of mood disorders. Trends in cognitive sciences. 2012 ; 16 : 61-71.
PubMed
28) Lee TS, Quek SY, Krishnan KR. Molecular imaging for depressive disorders. AJNR Am J Neuroradiol. 2014 ; 35 : S44-54.
PubMed
29) Kano M, Fukudo S, Tashiro A, et al. Decreased histamine H1 receptor binding in the brain of depressed patients. Eur J Neurosci. 2004 ; 20 : 803-10.
PubMed
30) Klumpers UM, Veltman DJ, Drent ML, et al. Reduced parahippocampal and lateral temporal GABAA- [11C] flumazenil binding in major depression : preliminary results. Eur J Nucl Med Mol imaging. 2010 ; 37 : 565-74.
PubMed
31) Drysdale AT, Grosenick L, Downar J, et al. Resting-state connectivity biomarkers define neurophysiological subtypes of depression. Nature medicine. 2017 ; 23 : 28-38.
PubMed
32) Van Oudenhove L, Crowell MD, Drossman DA, et al. Biopsychosocial aspects of functional gastrointestinal disorders. Gastroenterology. 2016.
PubMed
33) Al Omran Y, Aziz Q. Functional brain imaging in gastroenterology : to new beginnings. Nat Rev Gastroenterol Hepatol. 2014 ; 11 : 565-76.
PubMed
34) Tillisch K, Mayer EA, Labus JS. Quantitative meta-analysis identifies brain regions activated during rectal distension in irritable bowel syndrome. Gastroenterology. 2011 ; 140 : 91-100.
PubMed
35) Artigas J, Arts G, Babut M, et al. Towards a renewed research agenda in ecotoxicology. Environmental pollution. 2012 ; 160 : 201-6.
PubMed
36) Kano M, Muratsubaki T, Morishita J, et al. Influence of uncertain anticipation on brain responses to aversive rectal distension in patients with irritable bowel syndrome. Psychosomatic medicine. 2017 ; 79 : 988-99.
PubMed
37) Berman SM, Naliboff BD, Suyenobu B, et al. Reduced brainstem inhibition during anticipated pelvic visceral pain correlates with enhanced brain response to the visceral stimulus in women with irritable bowel syndrome. J Neurosci. 2008 ; 28 : 349-59. Epub 2008/01/11.
 
38) Dorn SD, Palsson OS, Thiwan SI, et al. Increased colonic pain sensitivity in irritable bowel syndrome is the result of an increased tendency to report pain rather than increased neurosensory sensitivity. Gut. 2007 ; 56 : 1202-9.
PubMed
39) Elsenbruch S, Rosenberger C, Enck P, et al. Affective disturbances modulate the neural processing of visceral pain stimuli in irritable bowel syndrome : an fMRI study. Gut. 2010 ; 59 : 489-95.
PubMed
40) Seminowicz DA, Labus JS, Bueller JA, et al. Regional gray matter density changes in brains of patients with irritable bowel syndrome. Gastroenterology. 2010 ; 139 : 48-57 e42.
 
41) Zeng F, Qin W, Yang Y, et al. Regional brain structural abnormality in meal-related functional dyspepsia patients : a voxel-based morphometry study. PloS one. 2013 ; 8 : e68383.
PubMed
42) Ly HG, Ceccarini J, Weltens N, et al. Increased cerebral cannabinoid-1 receptor availability is a stable feature of functional dyspepsia : a [F] MK-9470 PET study. Psychother Psychosom. 2015 ; 84 : 149-58.
 
43) Tominaga K, Tsumoto C, Ataka S, et al. Regional brain disorders of serotonin neurotransmission are associated with functional dyspepsia. Life sciences. 2015 ; 137 : 150-7.
PubMed
44) Niddam DM, Tsai SY, Lu CL, et al. Reduced hippocampal glutamate-glutamine levels in irritable bowel syndrome : preliminary findings using magnetic resonance spectroscopy. American J Gastroenterol. 2011 ; 106 : 1503-11.
 
45) Eisenstein M. Microbiome : Bacterial broadband. Nature. 2016 ; 533 : S104-6.
PubMed
P.101 掲載の参考文献
1) 日本食道学会, 編. 食道アカラシア取扱い規約 第4版. 東京 : 金原出版 ; 2012.
 
2) Mitani M, Kawamoto K, Funakawa I, et al. A case of esophageal achalasia followed by Parkinson's disease. Rinsho Shinkeigaku. 2005 ; 45 : 607-9.
PubMed
3) Qualman SJ, Haupt HM, Yang P, et al. Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson's disease. Gastroenterology. 1984 ; 87 : 848-56.
PubMed
4) Johnston BT, Colcher A, Gideon RM, et al. Repetitive proximal esophageal contractions : a new manometric finding and possible further link between Parkinson's disease and achalasia. Dysphagea. 2001 ; 16 : 186-9.
 
5) 岡住慎一, 高山亘, 岩崎好太郎, 他. 食道アカラシアの診断 : X線診断. 胃と腸. 2000 ; 35 : 1249-55.
 
6) Tanaka Y, Iwakiri K, Kawami N, et al. Predictors of a better outcome of pneumatic dilatation in patients with primary achalasia. J Gastroenterol. 2010 ; 45 : 153-8.
PubMed
7) Mikaeli J, Yaghoobi M, Montazeri G, et al. Efficacy of Botulinum Toxin injection before pneumatic dilatation in patients with idiopathic achalasia. Dis Esophagus. 2004 ; 17 : 213-7.
PubMed
8) Inoue H, Minami H, Kobayashi Y, et al. Peroral endoscopic myotomy (POEM) for esophageal achalasia. Endoscopy. 2010 ; 42 : 265-71.
PubMed
9) Zaninotto G, Costantini M, Rizzetto C, et al. Four hundred laparoscopic myotomies for esophageal achalasia. Ann Surg. 2008 ; 248 : 986-93.
PubMed
P.104 掲載の参考文献
1) 木下芳, 石原俊, 石村典. GERDの研究と診療における今後の展開. 日本消化器病学会雑誌. 2017 ; 114 : 1765-73.
Medical*Online
2) 藤原靖. 【GERD診療の進歩と問題点】GERD疫学 最近の動向. 日本消化器病学会雑誌. 2017 ; 114 : 1781-9.
 
3) Pfeiffer RF. Gastrointestinal dysfunction in Parkinson's disease. The Lancet Neurology. 2003 ; 2 : 107-16.
PubMed
4) Su A, Gandhy R, Barlow C, et al. Clinical and manometric characteristics of patients with Parkinson's disease and esophageal symptoms. Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus. 2017 ; 30 : 1-6.
PubMed
5) 岩切勝, 星野慎, 川見典. 【GERD診療の進歩と問題点】食道裂孔ヘルニアと酸逆流. 日本消化器病学会雑誌. 2017 ; 114 : 1774-80.
 
6) Leopold NA, Kagel MC. Pharyngo-esophageal dysphagia in Parkinson's disease. Dysphagia. 1997 ; 12 : 11-8 ; discussion 19-20.
 
7) 飯島克. 【GERD診療の進歩と問題点】GERDの内科的治療の進歩. 日本消化器病学会雑誌. 2017 ; 114 : 1790-6.
 
P.107 掲載の参考文献
1) Kemp WJ, Bashir A, Dababneh H, et al. Cushing's ulcer : Further reflections. Asian J Neurosurg. 2015 ; 10 : 87-94.
 
2) 川口実. 全身性疾患と消化管病変, 各論 2. 神経系疾患 1) Cushing潰瘍. 胃と腸. 2003 ; 38 : 501-5.
 
3) Sivakumar W, Spader HS, Scaife E, et al. A case of Cushing ulcer in an 8-month-old patient with medulloblastoma. Transl Pediatr. 2016 ; 5 : 85-9.
 
4) Yang X, Ren W, Zu H, et al. Evaluate the serum cortisol in patients with intracerebral hemorrhage. Clin Neurol Neurosurg. 2014 ; 123 : 127-30.
PubMed
5) Barugh AJ, Gray P, Shenkin SD, et al. Cortisol levels and the severity and outcomes of acute stroke : a systematic review. J Neurol. 2014 ; 261 : 533-45.
PubMed
6) Li ZM, Wang LX, Jiang LC, et al. Relationship between plasma cortisol levels and stress ulcer following acute and severe head injury. Med Princ Pract. 2010 ; 19 : 17-21.
 
7) Tseng CL, Chen YT, Huang CJ, et al. Short-term use of glucocorticoids and risk of peptic ulcer bleeding : a nationwide population-based case-crossover study. Aliment Pharmacol Ther. 2015 ; 42 : 599-606.
PubMed
8) Hoshino C, Satoh N, Narita M, et al. Another 'Cushing ulcer'. BMJ Case Rep. 2011 Apr 9 ; 2011. pii : bcr0220113888.
 
9) Luo JC, Shin VY, Liu ES, et al. Non-ulcerogenic dose of dexamethasone delays gastric ulcer healing in rats. Pharmacol Exp Ther. 2003 ; 307 : 692-8.
PubMed
10) Chi CW. Inhibition of the healing of gastric ulcer by glucocorticoid and its relation to proinflammatory cytokines. J Chin Med Assoc. 2009 ; 72 : 559-60.
PubMed
11) Luo JC, Shin VY, Liu ES, et al. Dexamethasone delays ulcer healing by inhibition of angiogenesis in rat stomachs. Eur J Pharmacol. 2004 ; 485 : 275-81.
PubMed
12) Zhou ML, Zhu L, Wang J, et al. The inflammation in the gut after experimental subarachnoid hemorrhage. J Surg Res. 2007 ; 137 : 103-8.
PubMed
13) Jin W, Wang HD, Hu ZG, et al. Transcription factor Nrf2 plays a pivotal role in protection against traumatic brain injury-induced acute intestinal mucosal injury in mice. J Surg Res. 2009 ; 157 : 251-60.
 
14) Zhao XD, Zhou YT. Effects of progesterone on intestinal inflammatory response and mucosa structure alterations following SAH in male rats. J Surg Res. 2011 ; 171 : e47-53.
 
15) Zhao X, Wu J, Zhang Y, et al. Alterations of intestinal labile zinc and cytokine production following subarachnoid hemorrhage in rats. Ann Clin Lab Sci. 2016 ; 46 : 622-6.
PubMed
P.110 掲載の参考文献
1) 米田政志, 島田忠人, 平石秀幸. 消化器疾患とストレス. Dokkyo Journal of Medical Sciences. 2006 ; 33 : 237-43.
 
2) 金子宏. ストレスと胃腸. からだの科学. 2006 ; 246 : 70-3.
 
3) Ueda J, Gosho M, Inui Y, et al. Prevalence of Helicobacter pylori infection by birth year and geographic area in Japan. Helicobacter. 2014 ; 19 : 105-10.
 
4) Kanno T, Iijima K, Abe Y, et al. A multicenter prospective study on the prevalence of Helicobacter pylori-negative and nonsteroidal anti-inflammatory drugs-negative idiopathic peptic ulcers in Japan. J Gastroenterol Hepatol. 2015 ; 30 : 842-8.
PubMed
5) Iijima K, Kanno T, Koike T, et al. Helicobacter pylori-negative, non-steroidal anti-inflammatory drug : negative idiopathic ulcers in Asia. World J Gastroenterol. 2014 ; 20 : 706-13.
PubMed
6) Wong GL, Wong VW, Chan Y, et al. High incidence of mortality and recurrent bleeding in patients with Helicobacter pylori-negative idiopathic bleeding ulcers. Gastroenterology. 2009 ; 137 : 525-31.
PubMed
7) Kanno T, Iijima K, Abe Y, et al. Helicobacter pylori-negative and non-steroidal anti-inflammatory drugs-negative idiopathic peptic ulcers show refractoriness and high recurrence incidence : Multicenter follow-up study of peptic ulcers in Japan. Dig Endosc. 2016 ; 28 : 556-63.
PubMed
8) Aoyama N, Kinoshita Y, Fujimoto S, et al. Peptic ulcers after the Hanshin-Awaji earthquake : increased incidence of bleeding gastric ulcers. Am J Gastroenterol. 1998 ; 93 : 311-6.
PubMed
9) Kanno T, Iijima K, Abe Y, et al. Peptic ulcers after the Great East Japan earthquake and tsunami : possible existence of psychosocial stress ulcers in humans. J Gastroenterol. 2013 ; 48 : 483-90.
PubMed
10) Kanno T, Iijima K, Koike T, et al. Accommodation in a refugee shelter as a risk factor for peptic ulcer bleeding after the Great East Japan Earthquake : a case-control study of 329 patients. J Gastroenterol. 2015 ; 50 : 31-40.
 
11) Levenstein S, Rosenstock S, Jacobsen RK, et al. Psychological stress increases risk for peptic ulcer, regardless of Helicobacter pylori infection or use of nonsteroidal anti-inflammatory drugs. Clin Gastroenterol Hepatol. 2015 ; 13 : 498-506.
PubMed
12) 中井吉英, 村上典子, 福永幹彦, 他. 心身症診断基準の作成とその活用-胃・十二指腸潰瘍. 日心療内誌. 1998 ; 2 : 119-21.
Medical*Online
13) 金子宏, 山口力. ヘリコバクター・ピロリ菌除菌時代における胃潰瘍 (心身症) 治療-1 男性症例を通して-. 心療内科. 2003 ; 7 : 232-8.
 
14) 金子宏. 消化性潰瘍. 心療内科. 2006 ; 10 : 225-32.
 
P.114 掲載の参考文献
1) Jung HK, Choung RS, Locke GR 3rd, et al. The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. Gastroenterology. 2009 ; 136 : 1225-33.
PubMed
2) Dudekula A, O'Connell M, Bielefeldt K. Hospitalizations and testing in gastroparesis. J Gastroenterol Hepatol. 2011 ; 26 : 1275-82.
PubMed
3) Soykan I, Sivri B, Sarosiek I, et al. Demography, clinical characteristics, psychological and abuse profiles, treatment, and long-term follow-up of patients with gastroparesis. Dig Dis Sci. 1998 ; 43 : 2398-404.
PubMed
4) Geeraerts B, Vandenberghe J, Van Oudenhove L, et al. Influence of experimentally induced anxiety on gastric sensorimotor function in humans. Gastroenterology. 2005 ; 129 : 1437-44.
PubMed
5) Rodriguez-Violante M, Cervantes-Arriaga A, Villar-Velarde A, et al. Prevalence of non-motor dysfunction among Parkinson's disease patients from a tertiary referral center in Mexico City. Clin Neurol Neurosurg. 2010 ; 112 : 883-5.
PubMed
6) Goetze O, Wieczorek J, Mueller T, et al. Impaired gastric emptying of a solid test meal in patients with Parkinson's disease using 13C-sodium octanoate breath test. Neurosci Lett. 2005 ; 375 : 170-3.
PubMed
7) Tanaka Y, Kato T, Nishida H, et al. Is there a delayed gastric emptying of patients with early-stage, untreated Parkinson's disease? An analysis using the 13C-acetate breath test. J Neurol. 2011 ; 258 : 421-6.
 
8) Marrinan S, Emmanuel AV, Burn DJ. Delayed gastric emptying in Parkinson's disease. Mov Disord. 2014 ; 29 : 23-32.
PubMed
9) Heetun ZS, Quigley EM. Gastroparesis and Parkinson's disease : a systematic review. Parkinsonism Relat Disord. 2012 ; 18 : 433-40.
PubMed
10) Pfeiffer RF. Gastrointestinal dysfunction in Parkinson's disease. Lancet Neurol. 2003 ; 2 : 107-16.
PubMed
11) Braak H, de Vos RA, Bohl J, et al. Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci Lett. 2006 ; 396 : 67-72.
 
12) Suzuki A, Asahina M, Ishikawa C, et al. Impaired circadian rhythm of gastric myoelectrical activity in patients with multiple system atrophy. Clin Auton Res. 2005 ; 15 : 368-72.
PubMed
13) Tanaka Y, Kato T, Nishida H, et al. Is there delayed gastric emptying in patients with multiple system atrophy? An analysis using the 13C-acetate breath test. J Neurol. 2012 ; 259 : 1448-52.
PubMed
14) Arai E, Arai M, Uchiyama T, et al. Subthalamic deep brain stimulation can improve gastric emptying in Parkinson's disease. Brain. 2012 ; 135 : 1478-85.
PubMed
P.119 掲載の参考文献
1) Ford AC, Lacy BE, Talley NJ. Irritable bowel syndrome. N Engl J Med. 2017 ; 376 : 2566-78.
PubMed
2) Fukudo S, Kanazawa M. Gene, environment, and brain-gut interactions in irritable bowel syndrome. J Gastroenterol Hepatol. 2011 ; 26 Suppl 3 : 110-5.
 
3) Drossman DA, Hasler WL. Rome IV-Functional GI Disorders : Disorders of Gut-Brain Interaction. Gastroenterology. 2016 ; 150 : 1257-61.
PubMed
4) Drossman DA. Functional Gastrointestinal Disorders : History, Pathophysiology, Clinical Features and Rome IV. Gastroenterology. 2016 ; 150 : 1262-79.
 
5) Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome : a meta-analysis. Clin Gastroenterol Hepatol. 2012 ; 10 : 712-21.
PubMed
6) Welgan P, Meshkinpour H, Beeler M. Effect of anger on colon motor and myoelectric activity in irritable bowel syndrome. Gastroenterology. 1988 ; 94 : 1150-6.
PubMed
7) Fukudo S, Suzuki J. Colonic motility, autonomic function, and gastrointestinal hormones under psychological stress on irritable bowel syndrome. Tohoku J Exp Med. 1987 ; 151 : 373-85.
PubMed
8) Mayer EA, Collins SM. Evolving pathophysiologic models of functional gastrointestinal disorders. Gastroenterology. 2002 ; 122 : 2032-48.
PubMed
9) Saito K, Kanazawa M, Fukudo S. Colorectal distention induces hippocampal noradrenaline release in rats : an in vivo microdialysis study. Brain Res. 2002 ; 947 : 146-9.
 
10) Saito K, Kasai T, Nagura Y, et al. Corticotropin-releasing hormone receptor 1 antagonist blocks brain-gut activation induced by colonic distention in rats. Gastroenterology. 2005 ; 129 : 1533-43.
PubMed
11) Tache Y. Corticotrophin-releasing factor 1 activation in the central amygdale and visceral hyperalgesia. Neurogastroenterol Motil. 2015 ; 27 : 1-6.
PubMed
12) Chey WD, Kurlander J, Eswaran S. Irritable bowel syndrome : a clinical review. JAMA. 2015 ; 313 : 949-58.
PubMed
P.122 掲載の参考文献
1) 第1章 定義・分類・診断基準. In : 日本消化器病学会関連研究会, 慢性便秘の診断・治療研究会, 編. 慢性便秘症診療ガイドライン 2017. 東京 : 南江堂 ; 2017. p.1-7.
 
2) Sbahi H, Cash BD. Chronic Constipation : a Review of Current Literature. Curr Gastroenterol Rep. 2015 ; 47.
PubMed
3) Munhoz RP, Moro a, Silveira-Moriyam L, et al. Non motor signs in Parkinson's disease : a review. Arq Neuropsiquiatr. 2015 ; 73 : 454-62.
 
4) Zhang T, Yu S, Guo P, et al. Nonmotor symptoms in Parkinson disease A cross-sectional observational study. Medicine. 2016 ; 95 ; 50 (e5400).
 
5) Ito T, Sakakibara R, Shimizu E, et al. Is major depression a risk for bladder, bowel, and sexual dysfunction? LUTS. 2012 ; 4 : 87-95.
PubMed
6) Hillila MT, Hamalainen J, Heikkinen ME, et al. Gastrointestinal complaints among subjects with depressive symptoms in the general population. Aliment Pharmacol Ther. 2008 ; 28 : 648-54.
PubMed
7) Sakakibara R, Odaka T, Uchiyama T, et al. Colonic transit time and rectonal videomanometry in Parkinson's disease. J Neurosurg Psychiatry. 2003 ; 74 : 268-72.
 
8) Afridi MI, Siddiqui MA, Ansari A. Gastrointestinal somatization in males and females with depressive disorder. J Pak Med Assoc. 2009 ; 59 : 675-9.
PubMed
9) Balsey J, Greenfield S, Candy D, et al. Systematic review : impact of constipation on quality of life in adults and children. Akiment Pharmachol ther. 2010 ; 31 : 938-49.
 
10) Mertz H, Naliboff B, Mayer E. Physiology of refractory chronic constipation. Am J Gastroenterol. 1999 ; 94 : 609-15.
PubMed
P.125 掲載の参考文献
1) Tateno F, Sakakibara R, Kishi M, et al. Incidence of emergency intestinal pseudo-obstruction in Parkinson's disease. J Am Geriatr Soc. 2011 ; 59 : 2373-5.
PubMed
2) 中島淳, 冬木晶子, 大久保秀則. 【臨床データーからみた機能性消化管障害へのアプローチ】画像検査からみた機能性消化管障害へのアプローチ. 日消誌. 2016 ; 113 : 1704-10.
 
3) 本郷道夫. 機能性消化管障害の将来展望 多元的解釈から一元的解釈へ. 日消誌. 2016 ; 113 : 1663-71.
Medical*Online
P.128 掲載の参考文献
1) 清水誠治. 急性出血性直腸潰瘍と宿便性潰瘍. 日本大腸肛門病会誌. 2001 ; 54 : 955-9.
 
2) 清水誠治. 特集 : 図説胃と腸用語集 2012, 宿便性潰瘍 (stercoral ulcer). 胃と腸. 2012 ; 47 : 781.
 
3) Grinvalsky HT, Bowerman CI. Stercoraceous ulcers of the colon : relatively neglected medical and surgical problem. JAMA. 1959 ; 171 : 1941-6.
 
4) Rozenblit AM, Cohen-Schwartz D, Wolf EL, et al. Case reports : stercoral perforation of the sigmoid colon―computed tomography findings. Clin Radiol. 2000 ; 55 : 727-9.
 
5) Heffernan C, Pachter HL, Megibow AJ, et al. Stercoral colitis leading to fatal peritonitis : CT findings. AJR. 2005 ; 184 : 1189-93.
PubMed
6) Hudson J, Abid Malik A. A fatal faecaloma stercoral colitis : a rare complication of chronic constipation. BMJ Case Rep. 2015.
 
7) Selye H, Winandy G, Gabbiani G. Production and prevention of stercoral ulcers in the rat. Am J Pathol. 1966 ; 48 : 299-303.
PubMed
8) 安尾信. 脳疾患に合併する直腸潰瘍の発生機序に関する研究. 聖マリアンナ医大誌. 1984 ; 12, 168-81.
 
9) 荒川正一. Stercoral ulcer (宿便性潰瘍) の臨床病理学的検討 (自験例の内視鏡および病理組織学的所見に基づいて). Gastroenterol Endosc. 1988 ; 30 : 3106-13.
 
10) Tateno F, Sakakibara R, Aiba Y, et al. Stercoral ulcer and colonic perforation in an individual with Parkinson's disease with constipation. J Am Geriatr Soc. 2016 ; 64 : 118-20.
 
P.130 掲載の参考文献
1) 日本大腸肛門病学会, 編. 便失禁診療ガイドライン 2017年版. 東京 : 南江堂 ; 2017. p.1-3.
 
2) Nakanishi N, Tatara K, Naramura H, et al. Urinary and fecal incontinence in a community-residing older population in Japan. J Am Geriatr Soc. 1997 ; 45 : 215-9.
 
3) Nelson R, Norton N, Cautley E, et al. Community-based prevalence of anal incontinence. JAMA. 1995 ; 274 : 559-61.
PubMed
4) Perry S, Shaw C, McGrother C, et al. Prevalence of faecal incontinence in adults aged 40 years or more living in the community. Gut. 2002 ; 50 : 480-4.
PubMed
5) Glickman S, Kamm MA. Bowel dysfunction in spinal-cord-injury patients. Lancet. 1996 ; 347 : 1651-3.
PubMed
6) Krogh K, Nielsen J, Djurhuus JC, et al. Colorectal function in patients with spinal cord lesions. Dis Colon Rectum. 1997 ; 40 : 1233-9.
PubMed
7) Verhoef M, Lurvink M, Barf HA, et al. High prevalence of incontinence among young adults with spina bifida : description, prediction and problem perception. Spinal Cord. 2005 ; 43 : 331-40.
PubMed
8) Sakakibara R, Fowler C, Takamichi H. Parkinson's disease. Chapter 12. In : Fowler C, Panicker J, Emmanuel A, editors. Pelvic Organ Dysfunction in Neurological Disease : Clinical Management and Rehabilitaion. Cambridge, UK : Cambridge University Press ; 2010. p.187-205.
 
9) Stiens SA, Bergman SB, Goetz LL. Neurogenic bowel dysfunction after spinal cord injury : clinical evaluation and rehabilitative management. Arch Phys Med Rehabil. 1997 ; 78 : S86-102.
PubMed
10) Nelson RL. Epidemiology of fecal incontinence. Gastroenterology. 2004 ; 126 : S3-7.
PubMed
11) Wald A, Bharucha AE, Cosman BC, et al. ACG clinical guideline : management of benign anorectal disorders. Am J Gastroenterol. 2014 ; 109 : 1141-57.
PubMed
12) Townsend MK, Matthews CA, Whitehead WE, et al. Risk factors for fecal incontinence in older women. Am J Gastroenterol. 2013 ; 108 : 113-9.
PubMed
P.135 掲載の参考文献
1) 青柳陽一郎, 粟飯原けい子. 摂食嚥下障害リハビリテーションABC総論 検査 マノメトリーでわかること. Medical Rehabilitation. 2017 : 107-12.
 
2) Hoffman MR, Mielens JD, Ciucci MR, et al. High-resolution manometry of pharyngeal swallow pressure events associated with effortful swallow and the Mendelsohn maneuver. Dysphagia. 2012 ; 27 : 418-26.
PubMed
3) Omari TI, Kritas S, Cock C, et al. Swallowing dysfunction in healthy older people using pharyngeal pressure-flow analysis. Neurogastroenterol Motil. 2014 ; 26 : 59-68.
PubMed
4) Bredenoord AJ, Fox M, Kahrilas PJ, et al. Chicago classification criteria of esophageal motility disorders defined in high resolution esophageal pressure topography1. Neurogastroenterol Motil. 2012 ; 24 : 57-65.
 
5) Kahrilas PJ, Bredenoord AJ, Fox M, et al. The Chicago Classification of esophageal motility disorders, v3.0. Neurogastroenterol Motil. 2015 ; 27 : 160-74.
 
P.138 掲載の参考文献
1) Palmer JB, Tanaka E, Siebens AA. Electromyography of the pharyngeal musculature : technical considerations. Archives Physical Med Rehabil. 1989 ; 70 : 283-7.
 
2) Ertekin C, Aydogdu I. Electromyography of human cricopharyngeal muscle of the upper esophageal sphincter. Muscle Nerve. 2002 ; 26 : 729-39.
PubMed
3) Kimura J. Electrodiagnosis in diseases of nerve and muscle : principles and practice. Ed. 4 ed. New York : Oxford University Press ; 2013.
 
4) Aldo O. Perotto (栢森良二訳). 筋電図のための解剖ガイド-四肢・体幹. 新潟 : 西村書店 ; 1997.
 
5) Perlman AL, Palmer PM, McCulloch TM, et al. Electromyographic activity from human laryngeal, pharyngeal, and submental muscles during swallowing. J Appl Physiol. 1999 ; 86 : 1663-9.
 
6) 青柳陽一郎, 嘉村雄飛, 佐藤新介, 他. 重度の嚥下障害を呈したWallenberg症候群患者の筋電図所見. 耳鼻と臨床. 2009 ; 55 : S158-63.
 
P.141 掲載の参考文献
1) Camilleri M, Parkman HP, Shafi MA, et al. Clinical guideline : management of gastroparesis. Am J Gastroenterol. 2013 : 108 : 18-37.
PubMed
2) Griffith GH, Owen GM, Kirkman S, et al. Meaurement of rate of gastric emptying using ehromium-51. Lancet. 1966 ; 1 : 1244-5.
 
3) Ghoos YF, Maes BD, Geypens BJ, et al. Measurement of gastric emptying rate of solids by means of a carbon-labeled octanic acid breath test. Gastroenterology. 1993 : 104 : 1640-7.
 
4) Arai E, Arai M, Uchiyama T, et al. Subthalamic deep brain stimulation can improve gastric emptying in Parkinson's disease. Brain. 2012 : 135 : 1478-85.
PubMed
P.144 掲載の参考文献
1) Chang FY. Electrogastrography : basic knowledge, recording, processing and its clinical applications. J Gastroenterol Hepatol. 2005 ; 20 : 502-16.
PubMed
2) 山中義崇, 朝比奈正人. 胃電図検査. 自律神経機能検査. 第5版. 東京 : 文光堂 ; 2015. p.361-4.
 
3) 金桶吉起. 胃電図検査. 自律神経機能検査. 第4版. 東京 : 文光堂 ; 2007. p.313-5.
 
4) Sakakibara Y, Asahina M, Suzuki A, et al. Gastric myoelectrical differences between Parkinson's disease and multiple system atrophy. Mov Disord. 2009 ; 24 : 1579-86.
PubMed
5) Koch KL. Diabetic gastropathy : gastric neuromuscular dysfunction in diabetes mellitus : a review of symptoms, pathophysiology, and treatment. Dig Dis Sci. 1999 ; 44 : 1061-75.
PubMed
6) Seligman WH, Low DA, Asahina M, et al. Abnormal gastric myoelectrical activity in postural tachycardia syndrome. Clin Auton Res. 2013 ; 23 : 73-80.
PubMed
P.147 掲載の参考文献
1) Whitehead WE, Delvaux M. Standardization of barostat procedures for testing smooth muscle tone and sensory thresholds in the gastrointestinal tract. The Working Team of Glaxo-Wellcome Research, UK. Dig Dis Sci. 1997 ; 42 : 223-41.
PubMed
2) Chial HJ, Camilleri C, Delgado-Aros S, et al. A nutrient drink test to assess maximum tolerated volume and postprandial symptoms : effects of gender, body mass index and age in health. Neurogastroenterol Motil. 2002 ; 14 : 249-53.
PubMed
3) Fruehauf H, Steingoetter A, Fox MR, et al. Characterization of gastric volume responses and liquid emptying in functional dyspepsia and health by MRI or barostat and simultaneous C-acetate breath test. Neurogastroenterol Motil. 2009 ; 21 : 697-e37.
PubMed
4) Fidler J, Bharucha AE, Camilleri M, et al. Application of magnetic resonance imaging to measure fasting and postprandial volumes in humans. Neurogastroenterol Motil. 2009 ; 21 : 42-51.
PubMed
5) Bouras EP, Delgado-Aros S, Camilleri M, et al. SPECT imaging of the stomach : comparison with barostat, and effects of sex, age, body mass index, and fundoplication. Single photon emission computed tomography. Gut. 2002 ; 51 : 781-6.
PubMed
P.150 掲載の参考文献
1) Fujita T, Kanno T, Kobayashi S. Gastroenteropancreatic endocrine system. In : Fujita T, Kanno T, Kobayashi S, editors. The Paraneuron. Tokyo : Springer-Verlag ; 1988. p.165-84.
 
2) Dockray GJ. Gastrointestinal hormones and the dialogue between gut and brain. J Physiol. 2014 ; 592 : 2927-41.
 
3) Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999 ; 402 : 656-60.
PubMed
4) Levin F, Edholm T, Schmidt PT, et al. Ghrelin stimulates gastric emptying and hunger in normal-weight humans. J Clin Endocrinol Metab. 2006 ; 91 : 3296-302.
PubMed
5) Ozawa T, Tokunaga J, Arakawa M, et al. Abnormal ghrelin secretion contributes to gastrointestinal symptoms in multiple system atrophy patients. J Neurol. 2013 ; 260 : 2073-7.
PubMed
P.154 掲載の参考文献
1) Kellow JE, Gill RC, Wingate DL. Prolonged ambulant recordings of small bowel motility demonstrate abnormalities in the irritable bowel syndrome. Gastroenterology. 1990 ; 98 : 1208-18.
PubMed
2) Fukudo S, Suzuki J. Colonic motility, autonomic function, and gastrointestinal hormones under psychological stress on irritable bowel syndrome. Tohoku J Exp Med. 1987 ; 151 : 373-85.
PubMed
3) Rogers J, Henry MM, Misiewicz JJ. Increased segmental activity and intraluminal pressures in the sigmoid colon of patients with the irritable bowel syndrome. Gut. 1989 ; 30 : 634-41.
PubMed
4) Kumar D, Wingate D. An illustrated guide to gastrointestinal motility, 2nd ed. London : Churchil Livingstone ; 1993.
 
5) Hinton JM, Lennard-Jones JE, Young AC. A new method for studying gut transit times using radiopaque markers. Gut. 1969 ; 10 : 842-7.
 
6) Read NW, et al. Measurement of small bowel transit in humans. In : Kamm M, Lennard-Johne J, editors. Gastrointestinal Transit. Pathophysiology and Pharmacology. Petersfield, UK : Wrightson Biomedical Publishing ; 1991. p.97-108.
 
7) Fukudo S, Nomura T, Muranaka M, et al. Brain-gut response to stress and cholinergic stimulation in irritable bowel syndrome. J Clin Gastroenterol. 1993 ; 17 : 133-41.
PubMed
8) Stanghellini V, Camilleri M, Malagelada JR. Chronic idiopathic intestinal pseudo-obstruction : clinical and intestinal manometric findings. Gut. 1987 ; 28 : 5-12.
PubMed
9) Schuffler MD. Chronic intestinal pseudo-obstruction. Medicine. 1981 ; 60 : 173-96.
PubMed
P.156 掲載の参考文献
1) 榊原隆次, 岸雅彦, 舘野冬樹, 他. 排便機能検査. In : 自律神経学会, 編. 自律神経機能検査 第5版. 東京 : 文光堂 ; 2015, p.368-70.
 
2) Sakakibara R, Okada T, Uchiyama T, et al. Colonic transit time, sphincter EMG, and rectoanal videomanometry in multiple system atrophy. Mov Disord. 2004 ; 19 : 924-9.
 
P.159 掲載の参考文献
1) Quigley EMM, Pfeiffer RF. Neurogastroenterology. Philadelphia : Butterworth-Heinemann ; 2004.
 
2) Wyndaele JJ, Kovindha A, Igawa Y, et al. Neurogic fecal incontinence. Neurourol Urodyn. 2010 ; 29 : 207-12.
 
3) 榊原隆次, 岸雅彦, 内山智之, 他. 定量的排便機能検査. 自律神経. 2009 ; 46 : 466-9.
 
4) Sakakibara R, Kishi M, Ogawa E, et al. Bladder, bowel, andsexual dysfunction in Parkinson's disease. Parkinson's Dis. 2011. Review Article.
 
5) 日本自律神経学会, 編. 自律神経機能検査 第5版. 2015 ; 368-70.
 
P.163 掲載の参考文献
1) Ching SS, Tan YK. Spectral analysis of bowel sounds in intestinal obstruction using an electronic stethoscope. World J Gastroenterol. 2012 ; 18 : 4585.
PubMed
2) Radnitz CL, Blanchard EB. Bowel sound biofeedback as a treatment for irritable bowel syndrome. Applied Psychophysiology and Biofeedback. 1988 ; 13 : 169-79.
 
3) Felder S, Margel D, Murrell Z, et al. Usefulness of bowel sound auscultation : a prospective evaluation. J Surg Educ. 2014 ; 71 : 768-73.
PubMed
4) Ulusar UD. Recovery of gastrointestinal tract motility detection using Naive Bayesian and minimum statistics. Comput Biol Med. 2014 ; 51 : 223-8.
PubMed
5) Yamaguchi K, Yamaguchi T, Odaka T, et al. Evaluation of gastrointestinal motility by computerized analysis of abdominal auscultation findings. J Gastroenterol Hepatol. 2006 ; 21 : 510-4.
PubMed
6) Liatsos C, Hadjileontiadis LJ, Mavrogiannis C, et al. Bowel sounds analysis : a novel noninvasive method for diagnosis of small-volume ascites. Dig Dis Sci. 2003 ; 48 : 1630-6.
PubMed
7) Ranta R, Louis-Dorr V, Heinrich C, et al. Digestive activity evaluation by multichannel abdominal sounds analysis, IEEE Transactions on Biomedical Engineering. 2010 ; 57 : 1507-19.
PubMed
8) Dimoulas C, Kalliris G, Papanikolaou G, et al. Long term signal detection, segmentation and summarization using wavelets and fractal dimension : a bioacoustics application in gastrointestinal motility monitoring. Comput Biol Med. 2007 ; 37 : 438-62.
PubMed
9) Yin Y, Yang W, Jiang H, et al. Bowel sound based digestion state recognition using artificial neural network. Biomedical Circuits and Systems Conference (BioCAS), 2015 IEEE. 2015 ; 1-4.
 
10) Yoshino H, Abe Y, Yoshino T, et al. Clinical application of spectral analysis of bowel sounds in intestinal obstruction Dis. Colon Rectum. 1990 ; 33 : 753-7.
PubMed
11) Kim KS, Seo JH, Ryu SH, et al. Estimation algorithm of the bowel motility based on regression analysis of the jitter and shimmer of bowel sounds Comput Methods Programs Biomed. 2011 ; 104 : 426-34.
PubMed
12) Kim KS, Seo JH, Song CG. Non-invasive algorithm for bowel motility estimation using a back-propagation neural network model of bowel sounds. Biomed Eng. 2011 ; 10 : 1-10.
PubMed
13) Craine BL, Silpa ML, O'Toole CJ. Two-dimensional positional mapping of gastrointestinal sounds in control and functional bowel syndrome patients. Digestive Diseases and Sciences. 2002 ; 47 : 1290-6.
PubMed
14) Dimoulas CA. Audiovisual spatial-audio analysis by means of sound localization and imaging : amultimedia healthcare framework in abdominal sound mapping, IEEE Transaction on Multimedia. 2016 ; 8 : 1969-76.
 
15) Ranta R, Louis-Dorr V, Heinrich C, et al. Towards an acoustic map of abdominal activity. Engineering in Medicine and Biology Society, 2003. Proceedings of the 25th Annual International Conference of the IEEE. 2003 ; 3 ; 2769-72.
 
16) Emoto T, Shono K, Abeyratne UR, et al. ARMA-based spectral bandwidth for evaluation of bowel motility by the analysis of bowel sounds. Physiological Measurement. 2013 ; 34 : 925.
PubMed
17) Hadjileontiadis LJ, Liatsos CN, Mavrogiannis CC, et al. Enhancement of bowel sounds by wavelet-based filtering, IEEE Transactions on Biomedical Engineering. 2000 ; 47 : 876-86.
PubMed
18) Dimoulas C, Kalliris G, Papanikolaou G, et al. Bowel-sound pattern analysis using wavelets and neural networks with application to long-term, unsupervised, gastrointestinal motility monitoring, Expert Systems with Applications. 2008 ; 34 : 26-41.
 
19) Emoto T, Abeyratne UR, Gojima Y, et al. Evaluation of human bowel motility using non-contact microphones. Biomedical Physics & Engineering Express. 2016 ; 2 : 045012.
 
20) Nonaka R, Emoto T, Abeyratne UR, et al. Automatic snore sound extraction from sleep sound recordings via auditory image modeling. Biomed Signal Process Control. 2016 ; 27 : 7-14.
 
21) Sato R, Emoto T, Gojima Y, et al. Automatic bowel motility evaluation technique for noncontact sound recordings. Applied Sciences. 2018 ; 8 : 999.
 
P.169 掲載の参考文献
1) Dickinson VA. Maintenance of anal continence : a review of pelvic floor physiology. Gut. 1978 ; 19 : 1163-74.
 
2) Kuijpers HC, Bleijenberg G, de Morree H. The spastic pelvic floor syndrome. Large bowel outlet obstruction caused by pelvic floor dysfunction : a radiological study. Int J Colorectal Dis. 1986 ; 1 : 44-8.
PubMed
3) Burhenne HJ. Intestinal evacuation study : a new roentgenologic technique. Radiol Clin. 1964 ; 33 : 79-84.
PubMed
4) Kruyt RH, Delemarre JB, Doornbos J, et al. Normal anorectum : dynamic MR imaging anatomy. Radiology. 1991 ; 179 : 159-63.
PubMed
5) Schoenenberger AW, Debatin JF, Guldenschuh I, et al. Dynamic MR defecography with a superconducting, open-configuration MR system. Radiology. 1998 ; 206 : 641-6.
PubMed
6) Vanbeckevoort D, Van Hoe L, Oyen R, et al. Pelvic floor descent in females : comparative study of colpocystodefecography and dynamic fast MR imaging. J Magn Reson Imaging. 1999 9 : 373-7.
PubMed
7) Rania S, Celine A, Francesca M, et al. On behalf of the ESUR and ESGAR Pelvic Floor Working Group, Magnetic resonance imaging of pelvic floor dysfunction-joint recommendations of the ESUR and ESGAR Pelvic Floor Working Group. Eur Radiol. 2017 ; 27 : 2067-85.
 
8) Bharucha AE, Dorn SD, Lembo A, et al. American Gastroenterological Association medical position statement on constipation. Gastroenterology. 2013 ; 144 : 211-7.
PubMed
9) 神山剛一, 澁澤三喜, 角田明良, 他. motion MRIを用いた骨盤内臓器及び骨盤底筋群の排便に及ぼす動的影響の観察. 日本大腸検査学会雑誌. 2002 ; 19 : 100-4.
 
P.173 掲載の参考文献
1) 肛門筋電図検査. In : 日本大腸肛門病学会. 便失禁診療ガイドライン 2017年度版1版. 東京 : 南江堂 ; 2017. p.43.
 
2) 榊原隆次. 排尿・排便検査の実際とその異常-Test for gastrointestinal tract and bladder autonomic function. Clin NeuroSci. 2017 ; 35 : 487-9.
 
3) Zhao L, Du H, Li B, et al. The Impact of Physiological Features on External Anal Sphincter Electromyography. J Neurol Neurophysiol. 2014 ; 5 : 227-33.
 
4) 中島久幸, 小杉光世, 坂下泰雄. 筋電図検査. 臨看. 1999 ; 25 : 2191-4.
 
5) 高橋知子, 角田明良. 国際標準に準拠した便失禁の診断と治療. III. 便失禁診断における各検査の役割と実際. 日本大腸肛門病会誌. 2015 ; 68 : 940-5.
 
6) Heymen S, Jones KR, Ringel Y, et al. Biofeedback treatment of fecal incontinence : a critical review. Dis Colon Rectum. 2001 ; 44 : 728-36.
PubMed
7) 柴田千晴, 高橋修, 榊原隆次, 他. 括約筋筋電図のとり方と読み方. In : 榊原隆次, 編. 神経因性膀胱ベッドサイドマニュアル1版. 東京 : 中外医学社 ; 2014. p.45-9.
 
P.176 掲載の参考文献
1) VII. 便失禁の検査法 A. 生理学的検査 3. 陰部神経伝導時間検査 (PNTML). In : 日本大腸肛門病学会, 編. 便失禁診療ガイドライン 2017年版. 東京 : 南江堂 ; 2017. P.42.
 
2) Kiff ES, Swash M. Slowed conduction in the pudendal nerves in idiopathic (neurogenic) faecal incontinence. Br J Surg. 1984 ; 71 : 614-6.
PubMed
3) 松岡弘芳, 正木忠彦, 吉敷智和, 他. 肛門内圧測定と陰部神経伝導速度の有用性と問題点. 日本大腸肛門病会誌. 2017 ; 70 : A62.
 
4) Tetzschner T, Sorensen M, Rasmussen OO, et al. Reliability of pudendal nerve terminal motor latency. Int J Colorectal Dis. 1997 ; 12 : 280-4.
PubMed
5) Wexner SD, Marchetti F, Salanga VD, et al. Neurophysiologic assessment of the anal sphincters. Dis Colon Rectum. 1991 ; 34 : 606-12.
PubMed
6) Diamant NE, Kamm MA, Wald A, et al. American gastroenterological association medical position statement on anorectal testing techniques. Gastroenterology. 1999 ; 116 : 732-60.
 
7) Suilleabhain CB, Horgan AF, McEnroe L, et al. The relationship of pudendal nerve terminal motor latency to squeeze pressure in patients with idiopathic fecal incontinence. Dis Colon Rectum. 2001 ; 44 : 666-71.
PubMed
8) Gilliland R, Altomare DF, Moreira H, et al. Pudendal neuropathy is predictive of failure following anterior overlapping sphincteroplasty. Dis Colon Rectum. 1998 ; 41 : 1516-22.
PubMed
9) Chen AS, Luchtefeld MA, Senagore AJ, et al. Pudendal nerve latency. Does it predict outcome of anal sphincter repair? Dis Colon Rectum. 1998 ; 41 : 1005-9.
PubMed
10) Bliss DZ, Mimura T, Bharucha A, et al. Assessment and conservative management of faecal incontinence and quality of life in adults. In : Abrams P, et al, Editors. Incontinence. 6th ed. International Consultation on Urological Diseases- International Continence Society ; 2017. p.1993-2085.
 
11) Paquette IM, Varma MG, Kaiser AM, et al. The American Society of Colon and Rectal Surgeons' clinical practice guideline for the treatment of fecal incontinence. Dis Colon Rectum. 2015 ; 58 : 623-36.
PubMed
P.180 掲載の参考文献
1) 村山繁雄. 高齢者ブレインバンクホームページ. www.mci.gr.jp/BrainBank/ (2018年12月12日校閲)
 
2) Ito S, Takao M, Hatsuta H, et al. Alpha-synuclein immunohistochemistry of gastrointestinal and biliary surgical specimens for diagnosis of Lewy body disease. Int J Clin Exp Pathol. 2014 ; 7 : 1714-23.
PubMed
3) Ikemura M, Saito Y, Sengoku R, et al. Lewy body pathology involves cutaneous nerves. J Neuropath Exp Neurol. 2008 ; 67 : 945-53.
PubMed
P.183 掲載の参考文献
1) Claesson MJ, Jeffery IB, Conde S, et al. Gut microbiota composition correlates with diet and health in the elderly. Nature. 2012 ; 488 : 178-84.
PubMed
2) Wu H, Tremaroli V, Backhed F. Linking microbiota to human diseases : a systems biology perspective. Trends Endocrinol Metab. 2015 ; 26 : 758-70.
 
3) Cryan JF, Dinan TG. Mind-altering microorganisms : the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci. 2012 ; 13 : 701-12.
PubMed
4) Nishimoto Y, Mizutani S, Nakajima T, et al. High stability of faecal microbiome composition in guanidine thiocyanate solution at room temperature and robustness during colonoscopy. Gut. 2016 ; 65 : 1574-5.
PubMed
5) 須田瓦, 西嶋傑, 高安伶奈, 他. 腸内細菌のメタゲノム解析・メタ16s解析. 東京 : 羊土社 ; 2016 : 28-38.
 
6) Cole JR, Wang Q, Fish JA, et al. Ribosomal Database Project : data and tools for high throughput rRNA analysis. Nucleic Acids Res. 2014 ; 42 : D633-42.
PubMed
7) DeSantis TZ, Hugenholtz P, Larsen N, et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol. 2006 ; 72 : 5069-72.
PubMed
8) Pruesse E, Quast C, Knittel K, et al. SILVA : a comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible with ARB. Nucleic Acids Res. 2007 ; 35 : 7188-96.
 
P.188 掲載の参考文献
1) 味村俊樹, 高津公子, 福島陽子, 他. 肛門機能検査 Starlet ano(R). 臨床消化器内科. 2016 ; 31 : 1761-6.
 
2) Rao SS, Azpiroz F, Diamant N, et al. Minimum standards of anorectal manometry. Neurogastroenterol Motil. 2002 ; 14 : 553-9.
PubMed
3) Frenckner B, Euler CV, Frenckner B, et al. Influence of pudendal block on the function of the anal sphincters. Gut. 1975 ; 16 : 482-9.
PubMed
4) Penninckx F, Lestar B, Kerremans R. The internal anal sphincter : mechanisms of control and its role in maintaining anal continence. Baillieres Clin Gastroenterol. 1992 ; 6 : 193-214.
PubMed
5) Rao SSC, Bharucha AE, Chiarioni G, et al. Anorectal disorders. Gastroenterology. 2016 ; 150 : 1430-42.
 
6) Grossi U, Carrington EV, Bharucha AE, et al. Diagnostic accuracy study of anorectal manometry for diagnosis of dyssynergic defecation. Gut. 2016 ; 65 : 447-55.
PubMed
7) Sangwan YP, Coller JA, Barrett RC, et al. Prospective comparative study of abnormal distal rectoanal excitatory reflex, pudendal nerve terminal motor latency, and single fiber density as markers of pudendal neuropathy. Dis Colon Rectum. 1996 ; 39 : 794-8.
PubMed
8) 味村俊樹. 便失禁の病態と論理的治療. 消化器内科. 2011 ; 52 : 275-84.
 
9) 味村俊樹. 便失禁の治療手順. Modern Physician. 2017 ; 37 : 68-73.
 
P.191 掲載の参考文献
1) Fukudo S, Kaneko H, Akiho H, et al. Evidence-based clinical practice guidelines for irritable bowel syndrome. J Gastroenterol. 2015 ; 50 : 11-30.
PubMed
P.196 掲載の参考文献
1) 矢島知治. 大腸の病気のすべて PART. 3 便秘. からだの科学. 2010 ; 267 : 98-101.
 
2) 飯田洋. 排便機能障害の治療戦略ガイド 薬剤に起因する便秘. Modern Physician. 2017 ; 37 : 41-3.
 
3) 大石了三, 園田正信. 薬のはなし 高齢者に特に慎重な投与を要する医薬品. 臨牀と研究. 2016 ; 93 : 1541-2.
 
4) 小川勝彦. 向精神薬の副作用. 重症心身障害の療育. 2016 ; 11 : 179-93.
 
5) Hert MD, Dockx L, Bernage C, et al. Prevalence and severity of antipsychotic related constipation in patients with schizophrenia : a retrospective descriptive study. BMC Gastroenterology. 2011 ; 11 : 17.
 
6) Stahl SM (田島治, 林健郎訳). スタールのヴィジュアル薬理学 抗精神病 薬の精神薬理. 東京 : 星和書店 ; 2001.
 
7) Hert MD, Hudya H, Dockx L, et al. Second-generation antipsychotics and constipation : a review of the literature. Europian Psychiatry. 2011 ; 26 : 34-44.
 
8) Shirazi A, Stubbs B, Gomez L, et al. Prevalence and predictors of clozapine-associated constipation : a systematic review and meta-analysis. Int J Mol Sci. 2016 ; 17 : 863.
PubMed
9) Stahl SM. Psychopharmacology of antidepressants. London : Martin Dunitz ; 1998.
 
10) 藤原修一郎, 加納亜希子, 田中優子. 誰も教えてくれなかった-慢性便秘の診かた ケース別対応 精神疾患患者の便秘. Medicina. 2016 ; 1411-4.
 
11) Lounsbery Jl, Medow MA, Green CG. Severe constipation associated with extended-release bupropion therapy. Am J Health Syst Pharm. 2008 ; 65 : 1530-2.
PubMed
12) Pagano G, Tan E, Haider JM, et al. Constipation is reduced by beta-blockers and increased by dopaminergic medications in Parkinson's disease. Parkinsonism and related disporders. 2015 ; 21 : 120-5.
 
13) Krogh K, Ostergaard K, Sabroe S, et al. Clinical aspects of bowel symptoms in Parkinson's disease. Acta neurol scand. 2008 ; 117 : 60-4.
PubMed
14) Ogawa E, Sakakibara R, Kishi M, et al. Constipation triggered the malignant syndrome in Parkinson's disease. Neurol sci. 2012 ; 33 : 347-50.
PubMed
15) 岡谷梨沙. 新薬レビュー イストラデフィン. Clinic Magazine. 2013 ; 534 : 58-60.
 
16) Meek PD, Evang SD, Tadrous M, et al. Overactive bladder drugs and constipation : a meta-analysis of randomized, placebo-controlled trials. Dig dis sci. 2011 ; 56 : 7-18.
PubMed
17) 宇野隆司, 松本健一. 新薬の紹介 過活動膀胱治療剤 イミダフェナシン. 日病薬誌. 2007 ; 43 : 1256-7.
 
18) 野澤優美子. 選択的β3アドレナリン受容体作動性過活動膀胱治療剤 ミラベグロン. ちば県薬誌. 2012 ; 58 : 369-73.
 
P.201 掲載の参考文献
1) Cheng C, Chan AO, Hui WM, et al. Coping strategies, illness perception, anxiety and depression of patients with idiopathic constipation : a population-based study. Aliment Pharmacol Ther. 2003 ; 18 : 319-26.
PubMed
2) Leung L, Riutta T, Kotecha J, et al. Chronic constipation : an evidence-based review. J Am Board Fam Med. 2011 ; 24 : 436-51.
PubMed
3) Suares NC, Ford AC. Systematic review : the effects of fibre in the management of chronic idiopathic constipation. Aliment Pharmacol Ther. 2011 ; 33 : 895-901.
PubMed
4) Murakami K, Sasaki S, Okubo H, et al. Food intake and functional constipation : a cross-sectional study of 3,835 Japanese women aged 18-20 years. J Nutr Sci Vitaminol. 2007 ; 53 : 30-6.
 
5) Muller-Lissner SA, Kamm MA, Scarpignato C, et al. Myths and misconceptions about chronic constipation. Am J Gastroenterol. 2005 ; 100 : 232-42.
PubMed
6) Chmielewska A, Szajewska H. Systematic review of randomized controlled trials : probiotics for functional constipation. World J Gastroenterol. 2010 ; 16 : 69-75.
PubMed
7) Miller LE, Ouwehand AC. Probiotic supplementation decreases intestinal transit time : meta-analysis of randomized controlled trials. World J Gastroenterol. 2013 ; 19 : 4718-25.
 
8) 文部科学省. 日本食品標準成分表 2015. 2015.
Medical*Online
9) 日本消化器病学会関連研究会 慢性便秘の診断・治療研究会, 編. 慢性便秘症診療ガイドライン 2017. 東京 : 南江堂 ; 2017.
 
P.205 掲載の参考文献
1) 原行弘. 在宅診療での消化管機能異常の対応のコツ. 診断と治療. 2010 ; 98 : 1483-8.
Medical*Online
2) 青柳邦彦. 慢性便秘症マネージメントの進歩. 臨床と研究. 2017 ; 94 : 505-9.
Medical*Online
3) 中島淳. 慢性便秘. 診断と治療. 2014 ; 102 : 1005-9.
Medical*Online
4) 鳥居明. 慢性便秘の治療法の基本 (食事と薬物, その他). 診断と治療. 2013 ; 101 : 273-7.
Medical*Online
5) 榊原隆次. 多系統萎縮症 vs パーキンソン病 自律神経症候から見た鑑別法 消化管障害 (解説). 自律神経. 2016 ; 53 : 218-21.
 
6) Sakakibara R, Kishi M, Ogawa E, et al. Bladder, bowel, and sexual dysfunction in Parkinson's disease. Parkinsons Dis. 2011 ; 2011 : 924605.
PubMed
7) 榊原隆次. 神経内科領域での便秘診療. Pharma Medica. 2017 ; 35.
Medical*Online
8) Ebert E. Gastrointestinal involvement in spinal cord injury : A clinical perspective. J Gastrointestin Liver Dis. 2012 ; 21 : 75-82.
PubMed
9) Allan L, McKeith I, Ballard C, et al. The prevalence of autonomic symptoms in dementia and their association with physical activity, activities of daily living and quality of life. Dement Geriatr Cogn Disord. 2006 ; 22 : 230-7.
PubMed
10) Rao SS, Beaty J, Chamberlain M, et al. Effects of acute graded exercise on human colonic motility. Am J Physiol. 1999 ; 276 : G1221-6.
PubMed
11) 原行弘. 排便障害とリハビリテーション. 排尿障害プラクティス. 2003 ; 11.
Medical*Online
12) De Schryver AM, Keulemans YC, Peters HP, et al. Effects of regular physical activity on defecation pattern in middle-aged patients complaining of chronic constipation. Scand J Gastroenterol. 2005 ; 40 : 422-9.
PubMed
13) 味村俊樹. 骨盤底筋協調運動障害を呈する便排出障害型便秘症に対する直腸バルーン排出訓練によるバイオフィードバック療法の効果に関する検討. バイオフィードバック研究. 2011 ; 38.
Medical*Online
14) Meshkinpour H, Selod S, Movahedi H, et al. Effects of regular exercise in management of chronic idiopathic constipation. Dig Dis Sci. 1998 ; 43 : 2379-83.
PubMed
P.215 掲載の参考文献
1) Wiesel P, Sally B. Chapter 12 Bowel dysfunction : assessment and management in the neurological patient. In : Norton C, Chelvanayagam S, editors. Bowel continence nursing. Bucks : Beaconsfield Publishers ; 2004. p.181-203.
 
2) 日本大腸肛門学会, 編. 失禁ガイドライン 2007年度版. 東京 : 南江堂 ; 2007. p.92.
 
3) Mariji Van K, Inge G. Chapter 12 Evidence for pelvic floor physical therapy for neurological diseases. In : Kari B, Barry B, Siv M, et al editors. Evidence-based Physical Therapy for the Pelvic Floor. London : Churchill Livingstone Elsever ; 2015. p.387-96.
 
4) Brocklehurst JC, Andrews K, Richards B, et al. Incidence and correlates of incontinence in stroke patients. J Am Geriatr Soc. 1985 ; 33 : 540-2.
PubMed
5) Nakayama H, Jorgensen HS, Pedersen PM, et al. Prevalence and risk factors of incontinence after stroke. The Copenhagen stroke study. Stroke. 1997 ; 28 : 58-62.
PubMed
6) Chia Y, Fowler CJ, Kamm MA, et al. Prevzlence of bowel dysfunction in patients with multiple sclerosis and bladder dysfunction. Journal of Neurology. 1995 ; 242 : 105-8.
PubMed
7) Bauer HJ, Firnhaber W, Winkler W. Prognostic criteria in multiple sclerosis. Annals of the new York Academy of Sciens. 1965 ; 122 : 542-51.
 
8) Edwards LL, Quigly EM, Pfeiffer RF. Gastrointestinal dysfunction in Parkinson's disease : frequency and pathophysiology. Neurology. 1992 ; 42 : 726-32.
 
9) Sakakibara R, Foweler C, Takamachi H. Parkinson's disease. Chapter 12. In : Fowler C, Panicker J, Emmanuel A, editors. Pelvic Organ Dysfunction in Neurological Disease. Cambridge : Cambridge University Press ; 2010.
 
10) 高坂哲, 石堂哲郎, 宮崎一興. 第5章 脊髄損傷患者の排便管理. In : 岩倉博光, 岩谷力, 土居信之, 編. 臨床リハビリテーション. 排尿排便障害 性機能障害. 東京 : 医歯薬出版 ; 1992. p.85-100.
 
11) 山中京子, 田村玉美, 佐久間 肇. 脊髄損傷者の排便に関する調査 退院時の排便問題は在宅生活でどう変化したか. リハビリテーション連携学会. 2012 ; 13 : 61.
 
12) 高橋真紀, 徳永恵子, 佐々木巌, 他. 脊髄損傷者における排便症状の現状-質問紙調査から-. 日本ストーマ・排泄リハビリテーション学会誌. 2011 ; 27 : 101.
 
13) 室岡陽子. 日本創傷・オストミー・失禁管理学会誌. 2011 ; 15 : 191.
Medical*Online
14) Glickman S, Kamm MM, Bowel dysfunction in spinal-cord-injury patients. Lancet. 1996 ; 347 : 1651-3.
 
15) Krogh K, Nielsen L, Djurhuus JC, et al. Colorectal function in patients with spinal cord lesions. Diseases of the Colon and Rectum. 1997 ; 40 : 1233-9.
 
16) Krogh K, Chistensen P, Sabroe S, et al. Neurogenic bowel dysfunction Score. Spinal cord. 2006 ; 22 : 625-31.
 
17) Lee Fancis. Neurogenic Bladder and bowel Management 2017. www.southportandormskirk.nhs.uk/
 
18) 川島みどり. 排便, 排ガスの技術 腰背部の温罨法 経験的知識. ナーシングトゥデイ. 1994 ; 9 : 8-12.
 
19) 細野恵子, 堀岡恒子, 久光雅美, 他. 高齢者における蒸気温熱シートによる下腹部湿熱加温の便秘改善効果. 臨床体温. 2010 ; 2 : 8-12.
Medical*Online
20) 菱沼典子, 山崎好美, 井垣通人, 他. 40℃と60℃の蒸気温熱シートによる腰部温罨法. 日本看護技術学会第5回学術集会講演集. 2006.
 
21) 藤野智子, 71. 腰部温罨法は排便促進に効果があるのか? In : 道又元裕, 監修. ケアの根拠 第2版. 東京 : 日本看護協会出版会 ; 2012. p.83.
 
22) 牛山杏子, 菱沼典子. 便秘ケアとしての温罨法の知識と技術. EB Nursing. 2009 ; 9 : 34-9.
 
23) Krasssioukov A, Eng JJ, Vennables B. Neurogenic bowel following spinal cord injury. In : Eng JJ, Teasell RW, Miller WC, et al, editors. Spinal cord injury rehabilitation evidence version 4. Canada. 2012. p.1-39.
 
24) 田中ゆうこ, 福田ゆかり. 脊髄損傷患者の便秘に対する指圧・マッサージの効果. リハビリナース. 2016 ; 9 : 92-9.
 
25) 菅野佳子, 玉垣努, 吉本美紀子, 他. 軽髄損傷者の排便障害における洗腸法の検討. 作業療法. 1993 ; 12 : 218-22.
 
26) Peter C, Gabriele B, Maureen C, et al. A Randomized, controlled trial of transanal irrigation versus conservative bowel management in spinal cord-injured patients. Gastroenterology. 2006 ; 131 : 738-47.
 
27) 味村俊樹, 角田明良, 千石淳, 他. 難治性排便障害に対する経肛門的洗腸療法 前向き多施設共同研究. 日本大腸肛門学会誌. 2018 ; 71 : 70-85.
 
28) 宇野良治. 神経因性大腸と盲腸瘻による順行性浣腸. 東京 ; 杏林書店 : 2006 ; 50.
 
29) Christensen P, Krogh K, Buntzen S, et al. Long-term outcome and safety of transanal irrigation for constipation and fecal incontinence. Dos. 2013 ; 15 : 67-78.
 
30) 高柳和江, 正木幸善. 脊髄損傷患者の排便障害者の盲腸ポート手術によるQOL向上. 日本整形外科看護研究誌. 2008 ; 3 : 48-55.
 
P.226 掲載の参考文献
1) Li J, Yuan M, Liu Y, et al. Incidence of constipation in stroke patients : A systematic review and meta-analysis. Medicine (Baltimore). 2017 ; 96 : e7225.
 
2) 野崎園子. 長期経過におけるパーキンソン病の困難症状への対応 2) 栄養障害・消化器症状. J Clini Rehabil. 2013 ; 22 : 361-6.
 
3) 館野冬樹, 榊原隆次. パーキンソン病の排便障害 (1) パーキンソン病のイレウスと便秘. 排尿障害プラクティス. 2013 ; 21 : 47-51.
 
P.232 掲載の参考文献
1) Stux G, Berman B, Pomeranz B. Basics of Acupuncture. 5th ed. Berlin Heidelberg : Springer-Verlag ; 2003 ; p.1-352.
 
2) Yin J, Chen JD. Gastrointestinal motility disorders and acupuncture. Auton Neurosci. 2010 ; 157 : 31-7.
 
3) Sato A, Sato Y, Schmidt RF. The impact of somatosensory input on autonomic functions. Rev Physiol Biochem Pharmacol. 1997 ; 130 : 1-328.
PubMed
4) Sato A, Sato Y, Suzuki A, et al. Neural mechanisms of the reflex inhibition and excitation of gastric motility elicited by acupuncture-like stimulation in anesthetized rats. Neurosci Res. 1993 ; 18 : 53-62.
PubMed
5) 山口真二郎, 岡田薫, 大沢秀雄, 他. 麻酔ラットの胃運動に及ぼす鍼通電刺激の効果. 自律神経. 1996 ; 33 : 39-45.
 
6) Noguchi E, Ohsawa H, Tanaka H, et al. Electro-acupuncture stimulation effects on duodenal motility in anesthetized rats. Jpn J Physiol. 2003 ; 53 : 1-7.
PubMed
7) Noguchi E, Hayashi H. Increases in gastric acidity in response to electroacupuncture stimulation of the hindlimb of anesthetized rats. Jpn J Physiol. 1996 ; 46 : 53-8.
PubMed
8) Imai K, Ariga H, Chen C, et al. Effects of electroacupuncture on gastric motility and heart rate variability in conscious rats. Auton Neurosci. 2008 ; 138 : 91-8.
PubMed
9) Takahashi T. Mechanism of acupuncture on neuromodulation in the gut-a review. Neuromodulation. 2011 ; 14 : 8-12.
 
10) Uchida S, Kagitani F, Sato-Suzuki I. Somatoautonomic reflexes in acupuncture therapy : A review. Auton Neurosci. 2017 ; 203 : 1-8.
PubMed
11) Ozaki N, Gebhart GF. Characterization of mechanosensitive splanchnic nerve afferent fibers innervating the rat stomach. Am J Physiol Gastrointest Liver Physiol. 2001 ; 281 : G1449-59.
PubMed
12) Ozaki N, Sengupta JN, Gebhart GF. Mechanosensitive properties of gastric vagal afferent fibers in the rat. J Neurophysiol. 1999 ; 82 : 2210-20.
 
13) Takaki M, Suzuki H, Nakayama S. Recent advances in studies of spontaneous activity in smooth muscle : ubiquitous pacemaker cells. Prog Biophys Mol Biol. 2010 ; 102 : 129-35.
PubMed
14) Dickman R, Schiff E, Holland A et al. Clinical trial : acupuncture vs. doubling the proton pump inhibitor dose in refractory heartburn. Aliment Pharmacol Ther. 2007 ; 26 : 1333-44.
PubMed
15) Zhang CX, Qin YM, Guo BR. Clinical study on the treatment of gastroesophageal reflux by acupuncture. Chin J Integr Med. 2010 ; 16 : 298-303.
PubMed
16) Zou D, Chen WH, Iwakiri K, et al. Inhibition of transient lower esophageal sphincter relaxations by electrical acupoint stimulation. Am J Physiol Gastrointest Liver Physiol. 2005 ; 289 : G197-201.
PubMed
17) Xu S, Hou X, Zha H, et al. Electroacupuncture accelerates solid gastric emptying and improves dyspeptic symptoms in patients with functional dyspepsia. Dig Dis Sci. 2006 ; 51 : 2154-9.
PubMed
18) Park YC, Kang W, Choi SM, et al. Evaluation of manual acupuncture at classical and nondefined points for treatment of functional dyspepsia : a randomized-controlled trial. J Altern Complement Med. 2009 ; 15 : 879-84.
PubMed
19) Jin Y, Zhao Q, Zhou K, et al. Acupuncture for functional dyspepsia : a single blinded, randomized, controlled trial. Evid Based Complement Alternat Med. 2015 ; 904926.
PubMed
20) Liu J, Huang H, Xu X, et al. Effects and possible mechanisms of acupuncture at ST36 on upper and lower abdominal symptoms induced by rectal distension in healthy volunteers. Am J Physiol Regul Integr Comp Physiol. 2012 ; 303 : R209-17.
PubMed
21) Lan L, Zeng F, Liu GJ, et al. Acupuncture for functional dyspepsia. Cochrane Database Syst Rev. 2014 ; Issue 10. Art. No. : CD008487.
 
22) Ho RST, Chung VCH, Wong CHL, et al. Acupuncture and related therapies used as add-on or alternative to prokinetics for functional dyspepsia : overview of systematic reviews and network meta-analysis. Sci Rep. 2017 ; 7 : 10320.
 
23) Schneider A, Enck P, Streitberger K, et al. Acupuncture treatment in irritable bowel syndrome. Gut. 2006 ; 55 : 649-54.
PubMed
24) Anastasi JK, McMahon DJ, Kim GH. Symptom management for irritable bowel syndrome : a pilot randomized controlled trial of acupuncture/moxibustion. Gastroenterol Nurs. 2009 ; 32 : 243-55.
PubMed
25) MacPherson H, Tilbrook H, Bland JM, et al. Acupuncture for irritable bowel syndrome : primary care based pragmatic randomised controlled trial. BMC Gastroenterol. 2012 ; 12 : 150.
PubMed
26) Zheng H, Li Y, Zhang W, et al. Electroacupuncture for patients with diarrhea-predominant irritable bowel syndrome or functional diarrhea : A randomized controlled trial. Medicine (Baltimore). 2016 ; 95 (24) : e3884.
PubMed
27) Manheimer E, Cheng K, Wieland LS, et al. Acupuncture for treatment of irritable bowel syndrome. Cochrane Database Syst Rev. 2012 ; Issue 5. Art. No : CD005111.
 
28) Park JW, Lee BH, Lee H. Moxibustion in the management of irritable bowel syndrome : systematic review and meta-analysis. BMC Complement Altern Med. 2013 ; 13 : 247.
PubMed
P.236 掲載の参考文献
1) Tanagho EA, Schmidt RA, Orvis BR. Neural stimulation for control of voiding dysfunction : a preliminary report in 22 patients with serious neuropathic voiding disorders. J Urol. 1989 ; 142 : 340-5.
PubMed
2) Matzel KE, Stadelmaier U, Hohenfellner M, et al. Electrical stimulation of sacral spinal nerves for treatment of faecal incontinence. Lancet. 1995 ; 346 : 1124-7.
PubMed
3) Wexner SD, Coller JA, Devroede G, et al. Sacral nerve stimulation for fecal incontinence : results of a 120-patient prospective multicenter study. Ann Surg. 2010 ; 251 : 441-9.
PubMed
4) Vaizey CJ, Kamm MA, Turner IC, et al. Effects of short term sacral nerve stimulation on anal and rectal function in patients with anal incontinence. Gut. 1999 ; 44 : 407-12.
PubMed
5) Matzel KE, Kamm MA, Stosser M, et al. Sacral spinal nerve stimulation for faecal incontinence : multicentre study. Lancet. 2004 ; 363 : 1270-6.
PubMed
6) Melenhorst J, Koch SM, Uludag O, et al. Sacral neuromodulation in patients with faecal incontinence : results of the first 100 permanent implantations. Colorectal Dis. 2007 ; 9 : 725-30.
PubMed
7) 山名哲郎, 高尾良彦, 吉岡和彦, 他. 便失禁に対する仙骨神経刺激療法 前向き多施設共同研究. 日本大腸肛門病学会誌. 2014 ; 67 : 371-9.
 
8) Hull T, Giese C, Wexner SD, et al. SNS Study Group. Long-term durability of sacral nerve stimulation therapy for chronic fecal incontinence. Dis Colon Rectum. 2013 ; 56 : 234-45.
 
9) Matzel KE, Stadelmaier U, Hohenberger W, Innovations in fecal incontinence : sacral nerve stimulation. Dis Colon Rectum. 2004 ; 47 : 1720-8.
PubMed
10) Tjandra JJ, Lim JF, Matzel K. Sacral nerve stimulation : an emerging treatment for faecal incontinence. ANZ J Surg. 2004 ; 74 : 1098-106.
PubMed
11) Kenefick NJ, Vaizey CJ, Cohen CR, et al. Double-blind placebo-controlled crossover study of sacral nerve stimulation for idiopathic constipation. Br J Surg. 2002 ; 89 : 1570-1.
PubMed
12) Kamm MA, Dudding TC, Melenhorst J, et al. Sacral nerve stimulation for intractable constipation. Gut. 2010 ; 59 : 333-40.
PubMed
13) Dinning PG, Hunt L, Patton V, et al. Treatment efficacy of sacral nerve stimulation in slow transit constipation : a two-phase, double-blind randomized controlled crossover study. Am J Gastroenterol. 2015 ; 110 : 733-40.
PubMed
14) Singleton C, Bakheit AM, Peace C. The Efficacy of Functional Electrical Stimulation of the Abdominal Muscles in the Treatment of Chronic Constipation in Patients with Multiple Sclerosis : A Pilot Study. Mult Scler Int. 2016 ; 2016 : 4860315.
PubMed
P.244 掲載の参考文献
1) 味村俊樹, 角田明良, 仙石淳, 他. 難治性排便障害に対する経肛門的洗腸療法 前向き多施設共同研究. 日本大腸肛門病会誌. 2018 ; 71 : 70-85.
 
2) Furlan JC, Urbach DR, Fehlings MG. Optimal treatment for severe neurogenic bowel dysfunction after chronic spinal cord injury : a decision analysis. Br J Surg. 2007 ; 94 : 1139-50.
PubMed
3) X. 特殊な病態の便失禁 A. 神経・脊髄疾患 (損傷). In : 日本大腸肛門病学会, 編. 便失禁診療ガイドライン 2017年版. 東京 : 南江堂 ; 2017. P.91-5.
 
4) IX. 便失禁の外科治療 B. 仙骨神経刺激療法. In : 日本大腸肛門病学会 編. 便失禁診療ガイドライン 2017年版. 東京 : 南江堂 ; 2017. P.74-5.
 
5) Schurch B, Reilly I, Reitz A, et al. Electrophysiological recordings during the peripheral nerve evaluation (PNE) test in complete spinal cord injury patients. World J Urol. 2003 ; 20 : 319-22.
PubMed
6) Rosen HR, Urbarz C, Holzer B, et al. Sacral nerve stimulation as a treatment for fecal incontinence. Gastroenterology. 2001 ; 121 : 536-41.
PubMed
7) Jarrett ME, Matzel KE, Christiansen J, et al. Sacral nerve stimulation for faecal incontinence in patients with previous partial spinal injury including disc prolapse. Br J Surg. 2005 ; 92 : 734-9.
PubMed
8) Holzer B, Rosen HR, Novi G, et al. Sacral nerve stimulation for neurogenic faecal incontinence. Br J Surg. 2007 ; 94 : 749-53.
PubMed
9) Gstaltner K, Rosen H, Hufgard J, et al. Sacral nerve stimulation as an option for the treatment of faecal incontinence in patients suffering from cauda equina syndrome. Spinal Cord. 2008 ; 46 : 644-7.
PubMed
10) Lombardi G, Del Popolo G, Cecconi F, et al. Clinical outcome of sacral neuromodulation in incomplete spinal cord-injured patients suffering from neurogenic bowel dysfunctions. Spinal Cord. 2010 ; 48 : 154-9.
PubMed
11) Haddad M, Besson R, Aubert D, et al. Sacral neuromodulation in children with urinary and fecal incontinence : a multicenter, open label, randomized, crossover study. J Urol. 2010 ; 184 : 696-701.
PubMed
12) Malone PS, Ransley PG, Kiely EM. Preliminary report : the antegrade continence enema. Lancet. 1990 ; 336 : 1217-8.
PubMed
13) Siddiqui AA, Fishman SJ, Bauer SB, et al. Long-term follow-up of patients after antegrade continence enema procedure. J Pediatr Gastroenterol Nutr. 2011 ; 52 : 574-80.
PubMed
14) Imai K, Shiroyanagi Y, Kim WJ, et al. Satisfaction after the Malone antegrade continence enema procedure in patients with spina bifida. Spinal Cord. 2014 ; 52 : 54-7.
PubMed
15) Teichman JM, Zabihi N, Kraus SR, et al. Long-term results for Malone antegrade continence enema for adults with neurogenic bowel disease. Urology. 2003 ; 61 : 502-6.
PubMed
16) Lees NP, Hodson P, Hill J, et al. Long-term results of the antegrade continent enema procedure for constipation in adults. Colorectal Dis. 2004 ; 6 : 362-8.
PubMed
17) Worsoe J, Christensen P, Krogh K, et al. Long-term results of antegrade colonic enema in adult patients : assessment of functional results. Dis Colon Rectum. 2008 ; 51 : 1523-8.
PubMed
18) Patel AS, Saratzis A, Arasaradnam R, et al. Use of antegrade continence enema for the treatment of fecal incontinence and functional constipation in adults : a systematic review. Dis Colon Rectum. 2015 ; 58 : 999-1013.
PubMed
19) Uno Y. Introducer method of percutaneous endoscopic cecostomy and antegrade continence enema by use of the Chait Trapdoor cecostomy catheter in patients with adult neurogenic bowel. Gastrointest Endosc. 2006 ; 63 : 666-73.
PubMed
20) Christensen P, Kvitzau B, Krogh K, et al. Neurogenic colorectal dysfunction- use of new antegrade and retrograde colonic wash-out methods. Spinal Cord. 2000 ; 38 : 255-61.
PubMed
21) Gerharz EW, Vik V, Webb G, et al. The value of the MACE (Malone antegrade colonic enema) procedure in adult patients. J Am Coll Surg. 1997 ; 185 : 544-7.
PubMed
22) IX. 便失禁の外科治療 C. 順行性洗腸法. In : 日本大腸肛門病学会, 編. 便失禁診療ガイドライン 2017年版. 東京 : 南江堂 ; 2017. P.76-7.
 
23) 5 . 治療 CQ5-12 慢性便秘症に順行性洗腸法は有効か? In : 日本消化器病学会関連研究会 慢性便秘の診断・治療研究会, 編. 慢性便秘症診療ガイドライン 2017. 東京 : 南江堂 ; 2017. P.87-8.
 
24) Colquhoun P, Kaiser R, Jr., Efron J, et al. Is the quality of life better in patients with colostomy than patients with fecal incontience? World J Surg. 2006 ; 30 : 1925-8.
PubMed
25) IX. 便失禁の外科治療 E. ストーマ造設術. In : 日本大腸肛門病学会, 編. 便失禁診療ガイドライン 2017年版. 東京 : 南江堂 ; 2017. P.80.
 
26) Kelly SR, Shashidharan M, Borwell B, et al. The role of intestinal stoma in patients with spinal cord injury. Spinal Cord. 1999 ; 37 : 211-4.
PubMed
27) Randell N, Lynch AC, Anthony A, et al. Does a colostomy alter quality of life in patients with spinal cord injury? A controlled study. Spinal Cord. 2001 ; 39 : 279-82.
PubMed
28) Rosito O, Nino-Murcia M, Wolfe VA, et al. The effects of colostomy on the quality of life in patients with spinal cord injury : a retrospective analysis. J Spinal Cord Med. 2002 ; 25 : 174-83.
PubMed
29) Branagan G, Tromans A, Finnis D. Effect of stoma formation on bowel care and quality of life in patients with spinal cord injury. Spinal Cord. 2003 ; 41 : 680-3.
PubMed
30) Safadi BY, Rosito O, Nino-Murcia M, et al. Which stoma works better for colonic dysmotility in the spinal cord injured patient? Am J Surg. 2003 ; 186 : 437-42.
PubMed
31) Luther SL, Nelson AL, Harrow JJ, et al. A comparison of patient outcomes and quality of life in persons with neurogenic bowel : standard bowel care program vs colostomy. J Spinal Cord Med. 2005 ; 28 : 387-93.
PubMed
32) Munck J, Simoens C, Thill V, et al. Intestinal stoma in patients with spinal cord injury : a retrospective study of 23 patients. Hepatogastroenterol. 2008 ; 55 : 2125-9.
 
33) Coggrave MJ, Ingram RM, Gardner BP, et al. The impact of stoma for bowel management after spinal cord injury. Spinal Cord. 2012 ; 50 : 848-52.
PubMed
34) Bolling HR, Staun M, Kalhauge A, et al. Bowel function and quality of life after colostomy in individuals with spinal cord injury. J Spinal Cord Med. 2016 ; 39 : 281-9.
 
35) Catena F, Wilkinson K, Phillips RKS. Untreatable faecal incontinence : Colostomy or colostomy and proctectomy? Colorectal Dis. 2002 ; 4 : 48-50.
PubMed

II 各論

P.254 掲載の参考文献
1) 厚生労働省. 平成26年患者調査の概況. www.whlw.go.jp./toukei/saikin/hw/kanja/14.
 
2) Scivoletto G, Fuoco U, Badiali D, et al. Gastrointestinal dysfunction following stroke. J Neurol Sci. 1997 ; 150 : S151.
 
3) Robain G, Chennevelle JM, Petit F, et al. Incidence of constipation after recent vascular hemiplegia : a prospective cohort of 152 patients. Rev Neurol (Paris). 2002 ; 158 (5 Pt 1) : 589-92.
 
4) Harari D, Norton C, Lockwood L, et al. Treatment of constipation and fecal incontinence in stroke patients : randomized controlled trial. Stroke. 2004 ; 35 : 2549-55.
PubMed
5) Bracci F, Badiali D, Pezzotti P, et al. Chronic constipation in hemiplegic patients. World J Gastroenterol. 2007 ; 13 : 3967-72.
PubMed
6) Kidd D, Lawson J, Nesbiit R, et al. The natural history of clinical consequences of aspiration in acute stroke. QJM. 1995 ; 88 : 409-3.
 
7) Moon HJ, Noh SE, Kim JH, et al. Diagnostic value of plain abdominal radiography in stroke patients with bowel dysfunction. Ann Rehabil Med. 2015 ; 39 : 243-52.
PubMed
8) Cheng X, Boza-Serrano A, Turesson MF, et al. Galectin-3 causes enteric neuronal loss in mice after left sided permanent middle cerebral artery occlusion, a model of stroke : Scientific RepoRts. 6 : 32893. DOI : 10.1038/srep32893.
 
9) Drake MJ, Fowler CJ, Griffiths D, et al. Neural control of the lower urinary and gastrointestinal tracts : supraspinal CNS mechanisms. Neurourol Urodyn. 2010 ; 29 : 119-27.
PubMed
10) Valentino RJ, Miselis RR, Pavcovich LA. Pontine regulation of pelvic viscera : pharmacological target for pelvic visceral dysfunctions. Trends Pharmacol Sci. 1999 ; 20 : 253-60.
PubMed
11) Nagano M, Ishimizu Y, Saitoh S, et al. The defecation reflex in rats : fundamental properties and the reflex center. Auton Neurosci. 2004 ; 111 : 48-56.
PubMed
12) Sakakibara R, Odaka T, Uchiyama T, et al. Colonic transit time and rectoanal videomanometry in Parkinson's disease. J Neurol Neurosurg Psychiatry. 2003 ; 74 : 268-72.
PubMed
13) Chia YW, Gill KP, Jameson JS, et al. Paradoxical puborectalis contraction is a feature of constipation in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry. 1996 ; 60 : 31-5.
PubMed
14) Vizzard MA, Brisson M, de Groat WC. Transneuronal labeling of neurons in the adult rat central nervous system following inoculation of pseudorabies virus into the colon. Cell Tissue Res. 2000 ; 299 : 9-26.
PubMed
15) Rouzade-Dominguez ML, Miselis R, Valentino RJ. Central representation of bladder and colon revealed by dual transsy- naptic tracing in the rat : substrates for pelvic visceral coordination. Eur J Neurosci. 2003 ; 18 : 3311-24.
 
16) Tateno F, Sakakibara R, Kishi M, et al. Brainstem stroke and increased anal tone. LUTS. 2012 ; 4 : 161-3.
PubMed
17) Nafees B, Lloyd AJ, Ballinger RS, et al. Managing neurogenic bowel dysfunction : what do patients prefer? A discrete choice experiment of patient preferences for transanal irrigation and standard bowel management. Patient Prefer Adherence. 2016 ; 10 : 195-204.
PubMed
P.259 掲載の参考文献
1) 重症頭部外傷治療・管理のガイドライン作成員会. 重症頭部外傷治療・管理のガイドライン 第3版. 東京 : 医学書院 ; 2013. p.76-7.
 
2) 山崎信吾, 橋本邦雄, 田畑 均, 他. 重症頭部外傷急性期の積極的栄養管理. 脳神経外科ジャーナル. 2000 ; 9 : 789-95.
 
3) Marshall LF. Head injury : recent past, present, and future. Neurosurgery. 2000 ; 47 : 546-61.
PubMed
4) Cushing H. Peptic ulcers and the interbrain. Surg Gynecol Obstet. 1932 ; 55 : 1.
 
5) Brown TH, Davidson PF, Larson GM. Acute gastritis occurring within 24 hours of severe head injury. Gastrointest Endosc. 1989 ; 35 : 37-40.
PubMed
6) Kamada T, Fusamoto H, Kawano S, et al. Gastrointestinal bleeding following head injury : a clinical study of 433 cases. J Trauma. 1977 ; 17 : 44-7.
 
7) Kunzman J. Management of bleeding stress ulcers. Am J Surg. 1970 ; 119 : 637-9.
PubMed
8) Ott L, Young B, Phillips R, et al. Altered gastric emptying in the head-injured patient : relationship to feeding intolerance. J Neurosurg. 1991 ; 74 : 738-42.
PubMed
9) Norton JA, Ott LG, McClain C, et al. Intolerance to enteral feeding in the brain-injured patient. J Neurosurg. 1988 ; 68 : 62-6.
 
10) Garrick T, Mulvihill S, Buack M, et al. Intracerebroventricular pressure inhibits gastric antral and duodenal contractility but not acid secretion in conscious rabbits. Gastroenterology. 1988 ; 95 : 26-31.
 
11) Rimmer DG. Gastric retention without mechanical obstruction. Arch Intern Med. 1966 ; 117 : 287-99.
 
12) 三毛牧夫. 腸閉塞症 1版. 東京 : メジカルビュー社 ; 2017. p.5-12.
 
13) Hang CH, Shi JX, Li JX, et al. Alterations of intestinal mucosa structure and barrier function following traumatic brain injury in rats. World J Gastroenterol. 2003 ; 9 : 2776-81.
 
14) Grotz MR, Deitch EA, Ding J, et al. Intestinal cytokine response after gut ischemia : role of gut barrier failure. Ann Surg. 1999 ; 229 : 478-86.
PubMed
15) 松本賢治, 尾原秀明, 北川雄光. NOMI (non-occlusive mesenteric ischemia) をいかに診断し, 治療するか. 日本腹部救急医学会雑誌. 2001 ; 31 : 1001-4.
 
16) 木所昭夫, 射場敏明. 非閉塞性腸管虚血症 (nonocclusive mesenteric ischemia, NOMI) の病態と治療. 日本集中治療医学会雑誌. 2007 ; 14 : 10-3.
 
P.266 掲載の参考文献
1) 日本神経学会, 監修. 認知症疾患診療ガイドライン 2010 CQ1-1 認知症の定義はどのようなものか. 第1版. 東京 : 医学書院 ; 2011.
 
2) 内閣府. 平成28年度高齢者白書 (概要版). 高齢者の健康・福祉. http://www8.cao.go.jp
 
3) 日本神経学会, 監修. 認知症疾患診療ガイドライン 2017 CQ1-5 我が国における認知症の有症率はどの程度か. 第1版. 東京 : 医学書院 ; 2017.
 
4) Alzheimer's disease International. World Alzheimer Report 2015. The Global Impact of Dementia an analyses of prevalence incidence cost and trends. 2015. https://www.alz.co.uk/research/WorldAlzheimerReport2015.pdf.
 
5) 粟田主一. II 認知症総合アセスメントの重要性. 東京都健康長寿医療センター自立促進と介護予防研究チーム, 編. 平成25年度老人保健事業推進費等補助金 (老人保健健康増進等事業分) 地域包括ケアシステムにおける認知症総合アセスメントの開発・普及と早期支援機能の実態に関する調査研究事業「認知症の総合アセスメント」平成26年. p.28.
 
6) 日本神経学会, 監修. 認知症疾患診療ガイドライン 2017 CQ1-6 認知症の病方による割合は変化しているか 第1版. 東京 : 医学書院 ; 2017. p.12-3.
 
7) 日本神経学会, 監修. 認知症疾患診療ガイドライン 2017 CQ3C-12 便秘の対応はどのように行うか 第1版. 東京 : 医学書院 ; 2017. p.114-5.
 
8) Allan L, Mckeith I, Ballard C, et al. The prevalence of autonomic symptoms in dementia and their association with physical activity, activities of daily living and quality life. Dement Geriatr Cogn Disord. 2006 ; 22 : 230-3.
PubMed
9) Zakrzewska-Pniewska B, Gawel M, Szmidt-Salkowska E, et al. Clinical and functional assessment of dysautonomia and its correlation in Alzheimer's disease. Am J Alzheimer's Dis Other Demwn. 2012 ; 27 : 592-9.
 
10) Danielle H. Chapter 13 Bowel Care in Old Age. In : Christine N. Sonya C editors. Bowel continence nursing. Buckinghamshire. Beconsfield Publishers ; 2004 ; 132-49.
 
11) Brocklehurst J, Dickinson, E et al. Laxatives and faecal incontinence in long-term care. Nursing standard. 1999 ; 52 : 32-6.
PubMed
12) Johanson JF, Irzarry F, Doughty A. Risk factors for fecal incontinence in a nursing home population. Jounal of clonical Gastroenterogy. 1997 ; 24 : 156-60.
 
13) Nelson R, Furner S, Jesudason V. Fecal incontinence in Wisconsin homes : prevalence and associations. Dis colon Rectum. 1998 ; 41 : 1226-9.
PubMed
14) Romero Y, Evans JM, Felming KC, et al. Constipation and fecal incontinence in the elderly population. Mayo Clin Proc. 1996 ; 71 (1) : 81-92.
 
15) 日本神経学会, 監修. 認知症疾患診療ガイドライン 2017 CQ2-3 認知症の認知機能障害を評価する際に有用な評価尺度と実施上の注意点は何か. 第1版. 東京 : 医学書院 ; 2017. p.25-7.
 
16) 粟田主一. II 認知症総合アセスメントの重要性. 東京都健康長寿医療センター自立促進と介護予防研究チーム, 編. 平成25年度老人保健事業推進費等補助金 (老人保健健康増進等事業分) 地域包括ケアシステムにおける認知症総合アセスメントの開発・普及と早期支援機能の実態に関する調査研究事業「認知症の総合アセスメント」平成26年. p.26.
 
17) 日本神経学会, 監修. 認知症疾患診療ガイドライン 2017 CQ6-9 Alzheimer型認知症のケアのポイントは何か. 東京 : 医学書院 ; 2017. p.233-4.
 
18) Rabins PV, Blacker D, Rovner BW, et al. APA Work Group on Alzheimer's disease. Practice guideline for the treatment of patients with Alzheimer's disease and other dementias. 2nd Edition. 2007 ; 164 (12 Suppl) : 5-56. https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/alzheimers.pdf
 
19) John FS, Sandra FS, Linda B. Prevalence of Constipation Symptoms in Fecally Incontinent Nursing Home Residents. J Am Geriatr Soc. 2009 ; 57 : 647-52. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2925174.
 
P.273 掲載の参考文献
1) 榊原隆次. 多系統萎縮症 vs パーキンソン病 自律神経症候から見た鑑別法 消化管障害 (解説). 自律神経. 2016 ; 53 : 218-21.
 
2) 榊原隆次, 土井啓員, 岸雅彦, 他. 消化管自律神経機能検査レビュー. 自律神経機能検査 (第5版). 日本自律神経学会 編. 東京 : 文光堂 ; 2015. p.342-4.
 
3) Tateno F, Sakakibara R, Kishi M, et al. Incidence of emergency intestinal pseudo-obstruction in Parkinson's disease. J Am Geriatr Soc. 2011 ; 59 : 2373-5.
PubMed
4) Recasens A, Dehay B. Alpha-synuclein spreading in Parkinson's disease. Front Neuroanat. 2014 Dec 18 ; 8 : 159. doi : 10.3389/fnana.2014.00159. eCollection 2014.
 
5) Abbott RD, Petrovitch H, White LR, et al. Frequency of bowel movements and the future risk of Parkinson's disease. Neurology. 2001 ; 57 : 456-62.
PubMed
6) Hawkes CH, Del Tredici K, Braak H. A timeline for Parkinson's disease. Parkinsonism and Related Disorders. 2010 ; 16 : 79-84.
PubMed
7) Gelpi E, Navarro-Otano J, Tolosa E, et al. Multiple organ involvement by alpha-synuclein pathology in Lewy body disorders. Mov Disord. 2014 ; 29 : 1010-8.
PubMed
8) Yan D, Zhang Y, Liu L, et al. Pesticide exposure and risk of Parkinson's disease : Dose-response meta-analysis of observational studies. Regul Toxicol Pharmacol. 2018 ; 96 : 57-63.
 
9) FeliceVD, Quigley EM, Sullivan AM, et al. Microbiota-gut-brain signalling in Parkinson's disease : Implications for non-motor symptoms. Parkinsonism Relat Disord. 2016 ; 27 : 1-8.
PubMed
10) Pan-Montojo F, Anichtchik O, Dening Y, et al. Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice. PLoS ONE. 2010 ; 5 : e8762.
PubMed
11) Svensson E, Horvath-Puho E, Thomsen RW, et al. Vagotomy and subsequent risk of Parkinson's disease. Ann Neurol. 2015 ; 78 : 522-9.
PubMed
12) Tateno F, Sakakibara R, Kishi M, et al. Constipation and metaiodobenzylguanidine myocardial scintigraphy abnormality. J Am Geriatr Soc. 2012 ; 60 : 185-7.
PubMed
13) Sakakibara R, Tateno F, Kishi M, et al. MIBG myocardial scintigraphy in pre-motor Parkinson's disease : a review. Parkinsonism Relat Disord. 2014 ; 20 : 267-73.
PubMed
14) Tateno H, Sakakibara R, Tateno F, et al. MIBG myocardial scintigraphy identifies premotor PD during a negative DAT scan period. J Am Geri Soc. 2015 ; 63 : 2428-30.
 
15) Doi H, Sakakibara R, Sato M, et al. Plasma levodopa peak delay and impaired gastric emptying in Parkinson's disease. J Neurol Sci. 2012 ; 319 : 86-8.
PubMed
16) 榊原隆次, 土井啓員, 舘野冬樹. レビー小体型認知症の消化管運動障害. 日本早期認知症学会誌. 2017 : 10 : 52-4.
Medical*Online
17) Ogawa E, Sakakibara R, Kishi M, et al. Constipation triggered the malignant syndrome in Parkinson's disease. Neurol Sci. 2012 ; 33 : 347-50.
PubMed
18) Tateno F, Sakakibara R, Aiba Y, et al. Stercoral ulcer and colonic perforation in an individual with Parkinson's disease with constipation. J Am Geriatr Soc. 2016 ; 64 : e118-20.
 
19) Tateno F, Sakakibara R, Yokoi Y, et al. Levodopa ameliorated anorectal constipation in de novo Parkinson's disease : The QL-GAT study. Parkinsonism Relat Disord. 2011 ; 17 : 662-6.
PubMed
20) Tateno H, Sakakibara R, Shiina S, et al. Transdermal dopamine agonist ameliorates gastric emptying in Parkinson's disease. J Am Geriatr Soc. 2015 ; 63 : 2416-8.
PubMed
21) Tateno H, Sakakibara R, Shiina S, et al. Transdermal dopamine agonist ameliorates gastric emptying in Parkinson's disease. J Am Geri Soc. 2015 ; 63 : 2416-8.
 
22) Arai E, Arai M, Uchiyama T, et al. Subthalamic deep brain stimulation can improve gastric emptying in Parkinson's disease. Brain. 2012 ; 135 : 1478-85.
PubMed
23) Rao SS, Beaty J, Chamberlain M, et al. Effects of acute graded exercise on human colonic motility. Am J Physiol. 1999 ; 276 (5 Pt 1) : G1221-6.
 
24) Sakakibara R, Tsunoyama K, Hosoi H, et al. Influence of body position on defecation in humans. Low Urin Tract Symptoms. 2010 ; 2 : 16-21.
PubMed
25) Sakakibara R, Yamaguchi T, Uchiyama T, et al. Calcium polycarbophil improves constipation in primary autonomic failure and multiple system atrophy subjects. Mov Disord. 2007 ; 22 : 1672-3.
PubMed
26) Ondo WG, Kenney C, Sullivan K, et al. Placebo-controlled trial of lubiprostone for constipation associated with Parkinson disease. Neurology. 2012 ; 78 : 1650-4.
PubMed
27) Sakakibara R, Doi H, Sato M, et al. Nizatidine ameliorates slow transit constipation in Parkinson's disease. J Am Geriatr Soc. 2015 ; 63 : 399-401.
PubMed
28) Liu Z, Sakakibara R, Odaka T, et al. Mosapride citrate, a novel 5-HT4 agonist and partial 5-HT3 antagonist, ameliorates constipation in parkinsonian patients. Mov Disord. 2005 ; 20 : 680-6.
PubMed
29) Doi H, Sakakibara R, Sato M, et al. Dietary herb extract rikkunshi-to ameliorates gastroparesis in Parkinson's disease : a pilot study. Eur Neurol. 2014 ; 71 : 193-5.
PubMed
30) Sakakibara R, Odaka T, Lui Z, et al. Dietary herb extract dai-kenchu-to ameliorates constipation in parkinsonian patients (Parkinson's disease and multiple system atrophy). Mov Disord. 2005 ; 20 : 261-2.
PubMed
31) Cadeddu F, Bentivoglio AR, Brandara F, et al. Outlet type constipation in Parkinson's disease : results of botulinum toxin treatment. Aliment Pharmacol Ther. 2005 ; 22 : 997-1003.
PubMed
P.279 掲載の参考文献
1) Papp MI, Kahn JE, Lantos PL, et al. Glial cytoplasmic inclusion in the CNS of patients with multiple system atrophy (striatonnigral degeneration, olivopontocellebellar atrophy and Shy-Drager syndrome). J Neurol Sci. 1989 ; 94 : 79-100.
PubMed
2) Gilman S, Wenning GK, Low PA, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology. 2008 ; 71 : 670-6.
PubMed
3) Yamamoto T, Sakakibara R, Uchiyama T, et al. Questionnaire-based assessment of pelvic organ dysfunction in multiple system atrophy. Mov Disord. 2009 ; 24 : 972-8.
PubMed
4) Yamamoto T, Sakakibara R, Uchiyama T, et al. Pelvic organ dysfunction is more prevalent and severe in MSA-P compared to Parkinson's disease. Neurourol Urodyn. 2011 ; 30 : 102-7.
PubMed
5) Sakakibara R, Odaka T, Uchiyama T, et al. Colonic transit time, sphincter EMG, and rectoanal videomanometry in multiple system atrophy. Mov Disord. 2004 ; 19 : 924-9.
 
6) Stocchi F, Badiali D, Vacca L, et al. Anorectal function in multiple system atrophy and Parkinson's disease. Mov Disord. 2000 ; 15 : 71-6.
PubMed
7) Suzuki A, Asahina M, Ishikawa C, et al. Impaired circadian rhythm of gastric myoelectrical activity in patients with multiple system atrophy. Clin Auton Res. 2005 ; 15 : 368-72.
PubMed
8) Sakakibara Y, Asahina M, Suzuki A, et al. Gastric myoelectrical differences between Parkinson's disease and multiple system atrophy. Mov Disord. 2009 ; 24 : 1579-86.
PubMed
9) Tanaka Y, Kato T, Nishida H, et al. Is there delayed gastric emptying in patients with multiple system atrophy? An analysis using the 13C-acetate breath test. J Neurol. 2012 ; 259 : 1448-52.
PubMed
10) Sakakibara R, Kishi M, Ogawa E, et al. Multiple-system atrophy presenting with low rectal compliance and bowel pain. Mov Disord. 2010 ; 25 : 1516-8.
PubMed
11) Yamamoto T, Sakakibara R, Uchiyama T, et al. When is Onuf's nucleus involved in multiple system atrophy? A sphincter electromyography study. J Neurol Neurosurg Psychiatry. 2005 ; 76 : 1645-8.
PubMed
12) Sakakibara R, Yamaguchi T, Uchiyama T, et al. Calcium polycarbophil improves constipation in primary autonomic failure and multiple system atrophy subjects. Mov Disord. 2007 ; 22 : 1672-3.
PubMed
13) Liu Z, Sakakibara R, Odaka T, et al. Mosapride citrate, a novel 5-HT4 agonist and partial 5-HT3 antagonist, ameliorates constipation in parkinsonian patients. Mov Disord. 2005 ; 20 : 680-6.
PubMed
14) Sakakibara R, Odaka T, Lui Z, et al. Dietary herb extract dai-kenchu-to ameliorates constipation in parkinsonian patients (Parkinson's disease and multiple system atrophy). Mov Disord. 2005 ; 20 : 261-2.
PubMed
P.283 掲載の参考文献
1) Del Giudice E, Staiano A, Capano G, et al. Gastrointestinal manifestations in children with cerebral palsy. Brain Dev. 1999 ; 21 : 307-11.
PubMed
2) Strauss D, Cable W, Shavelle R. Causes of excess mortality in cerebral palsy. Dev Med Child Neurol. 1999 ; 41 : 580-5.
PubMed
3) Kitazumi E. Improvement of QOL by advance in the management of respiratory disorders, dysphagia and upper gastrointestinal disorders in children with severe cerebral palsy. No To Hattatsu. 1998 ; 30 : 207-14.
PubMed
4) Penagini F, Mameli C, Fabiano V, et al. Dietary intakes and nutritional issues in neurologically impaired children. Nutrients. 2015 ; 7 : 9400-15.
PubMed
5) Thomson M, Rao P, Rawat D, et al. Percutaneous endoscopic gastrostomy and gastro-oesophageal reflux in neurologically impaired children. World J Gastroenterol. 2011 ; 17 : 191-6.
PubMed
6) Miyazawa R, Tomomasa T, Kaneko H, et al. Effects of pectin liquid on gastroesophageal reflux disease in children with cerebral palsy. BMC Gastroenterol. 2008 ; 8 : 11.
PubMed
7) Ferluga ED, Sathe NA, Krishnaswami S, et al. Surgical intervention for feeding and nutrition difficulties in cerebral palsy : a systematic review. Dev Med Child Neurol. 2014 ; 56 : 31-43.
PubMed
8) Brun AC, Stordal K, Jahannesdottir GB, et al. Nissen fundoplication in children with cerebral palsy : influence on rate of gastric emptying and postprandial symptoms in relation to protein source in caloric liquid meals. Clin Nutr. 2013 ; 32 : 619-23.
 
9) Ozturk M, Oktem F, Kisioglu N, et al. Bladder and bowel control in children with cerebral palsy : case-control study. Croat Med J. 2006 ; 47 : 264-70.
PubMed
10) Veugelers R, Benninga MA, Calis EA, et al. Prevalence and clinical presentation of constipation in children with severe generalized cerebral palsy. Dev Med Child Neurol. 2010 ; 52 : e216-21.
PubMed
11) Park ES, Park CI, Cho SR, et al. Colonic transit time and constipation in children with spastic cerebral palsy. Arch Phys Med Rehabil. 2004 ; 85 : 453-6.
PubMed
12) Awan WA, Masood T. Role of stretching exercises in the management of constipation in spastic cerebral palsy. J Ayub Med Coll Abbottabad. 2016 ; 28 : 798-801.
PubMed
13) Elbasan B, Bezgin S. The effects of reflexology on constipation and motor functions in children with cerebral palsy. Pediatr Neonatol. 2017.
PubMed
14) Jancar J, Speller CJ. Fatal intestinal obstruction in the mentally handicapped. J Intellect Disabil Res. 1994 ; 38 (Pt 4) : 413-22.
 
15) Delgadillo X, Belpaire-Dethiou MC, Chantrain C, et al. Arteriomesenteric syndrome as a cause of duodenal obstruction in children with cerebral palsy. J Pediatr Surg. 1997 ; 32 : 1721-3.
PubMed
P.286 掲載の参考文献
1) Popescu BF, Lennon VA, Parisi JE, et al. Neuromyelitis optica unique area postrema lesions : nausea, vomiting, and pathogenic implications. Neurology. 2011 ; 76 : 1229-37.
PubMed
2) Apiwattanakul M, Popescu BF, Matiello M, et al. Intractable vomiting as the initial presentation of neuromyelitis optica. Ann Neurol. 2010 ; 68 : 757-61.
PubMed
3) Wingerchuk DM, Banwell B, Bennett JL, et al. International Panel for NMO Diagnosis. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015 ; 85 : 177-89.
PubMed
4) Sawai S, Sakakibara R, Kanai K, et al. Isolated vomiting due to a unilateral dorsal vagal complex lesion. Eur Neurol. 2006 ; 56 : 246-8.
PubMed
P.294 掲載の参考文献
1) Krogh K, Nielsen J, Djurhuus JC, et al. Colorectal function in patients with spinal cord lesions. Dis Colon Rectum. 1997 ; 40 : 1233-9.
PubMed
2) De Looze D, Van Laere M, De Muynck M, et al. Constipation and other chronic gastrointestinal problems in spinal cord injury patients. Spinal Cord. 1998 ; 36 : 63-6.
PubMed
3) 乃美昌司, 仙石淳. 脊髄損傷者における排便機能障害についての聞き取り調査. 日脊障医誌. 2011 ; 24 : 170-1.
 
4) Coggrave N, et al. Management of neurogenic bowel dysfunction in the community after spinal cord injury : a postal survey in the United Kingdom. Spinal Cord. 2009 ; 47 : 323-33.
PubMed
5) Dr Maureen Coggrave (Chair) and Guideline Development Group 2012 Guidelines for Management of Neurogenic Bowel Dysfunction in Individuals with Central Neurological Conditions. 2012. https://www.mascip.co.uk/wp-content/uploads/2015/02/CV653N-Neurogenic-Guidelines-Sept-2012.pdf#search=%27CPUCC_Neuro+Bowel+Dysfunc+Guide_11.indd+60%27
 
6) 日本消化器病学会関連研究会, 慢性便秘の診断・治療研究会, 編. 慢性便秘症診療ガイドライン 2017. 東京 : 南江堂 ; 2017.
 
7) Krogh K, Emmanuel A, Perrouin-Verbe B, et al. International spinal cord injury bowel function basic data set (Version 2.0). Spinal Cord. 2017 ; 55 : 692-8.
 
8) 乃美昌司, 柳内章宏, 仙石淳. 国際脊損者排便機能調査票による聞き取り調査. 日脊障医誌. 2014 ; 27 : 52-3.
 
9) 神山剛一. 排便機能評価法. 総合リハ. 2005 ; 33 : 115-9.
 
10) 岡崎啓介. 放射線不透過マーカーを用いた大腸通過時間の測定. 日本大腸肛門病会誌. 2010 ; 63 : 339-45.
 
11) Christensen P, Bazzocchi G, Coggrave M, et al. A randomized, controlled trial of transanal irrigation versus conservative bowel management in spinal cord injured patients. Gastroenterology. 2006 ; 131 : 738-47.
PubMed
12) 味村俊樹, 角田明良, 仙石淳, 他. 難治性排便障害に対する経肛門的洗腸療法 前向き多施設共同研究. 日本大腸肛門病学会誌. 2018 ; 71 : 70-85.
 
13) Coggrave M, Norton C, Cody JD. Management of faecal incontinence and constipation in adults with central neurological diseases. Cochrane Database Syst Rev. 2014 ; 13 : Review.
 
P.298 掲載の参考文献
1) Fowler CJ, Panicker JN, Emmanuel A. Pelvic organ dysfunction in neurological disease : clinical management and rehabilitation. Cambridge University Press ; 2010. p.228-30.
 
2) Dibley L, Coggrave M, McClurg D, et al. "It's just horrible" : a qualitative study of patients' and carers' experiences of bowel dysfunction in multiple sclerosis. J Neurol. 2017 ; 264 : 1354-61.
 
3) Cotterill N, Madersbacher H, Wyndaele JJ, et al. Neurogenic bowel dysfunction : Clinical management recommendations of the Neurologic Incontinence Committee of the Fifth International Consultation on Incontinence 2013. Neurourol Urodyn. 2018 ; 37 : 46-53.
PubMed
4) Lawthom C, Durdey P, Hughes T. Constipation as a presenting symptom. Lancet. 2003 ; 362 : 958.
PubMed
5) Marola S, Ferrarese A, Gibin E, et al. Anal sphincter dysfunction in multiple sclerosis : an observation manometric study. Open Med (Wars). 2016 ; 11 : 509-17.
PubMed
P.303 掲載の参考文献
1) 小野敏子, 稲葉裕. 学齢期における二分脊椎児のQOL-健常児との比較研究-. 小児保健研究. 2008 ; 67 : 331-9.
 
2) 野村貞宏. 二分脊椎を合併する症候群と最新の診断・治療. 小児科診療. 2007 ; 9 : 1487-93.
Medical*Online
3) Oi S, Matsumoto S. A proposed grading and scoring system for spina bifida : Spina Bifida Neurological Scale (SBNS). Child Nerv Syst. 1992 ; 8 : 337-42.
PubMed
4) Velde SV, Pratte L, Verhelst H, et al. Colon transit time and anorectal manometry in children and young adults with spina bifida. Int J Colorectal Dis. 2013 ; 28 : 1547-53.
 
5) Arhan P, Faverdin C, Devroede G, et al. Anorectal motility after surgery for spina bifida. Dis Colon Rectum. 1984 ; 27 : 159-63.
PubMed
6) Marte A, Cotrufo AM, Di Iorio G, et al. Electromyographic and manometric anorectal evaluation in children affected by neuropathic bladder secondary to myelomeningocele. Minerva Pediatr. 2001 ; 53 : 171-6.
PubMed
7) Hensle TW, Reiley EA, Chang DT. The Malone antegrade continence enema procedure in the management of patients with spina bifida. J Am Coll Surg. 1988 ; 186 : 669-74.
 
8) 松野大輔, 白柳慶之, 鈴木万里, 他. 二分脊椎患者に対するMalone antegrade continence enema (MACE) 造設術の検討. 日本小児泌尿器科学会雑誌. 2008 ; 17 : 128-31.
Medical*Online
9) 宮崎一興, 鈴木康之, 石堂哲郎. 膀胱直腸障害に関する最近の研究. 総合リハビリテーション. 1998 ; 16 : 39-43.
 
10) 岩川愛一郎, 妹尾康平, 高野徳昭. 小児二分脊椎症患者における洗腸療法の有用性. 西日本泌尿器科. 1992 ; 54 : 1542-4.
Medical*Online
11) Lansen-Koch SM, Govaert B, Oerlemans D, et al. Sacral nerve modulation for defaecation and micturition disorder in patients with spina bifida. Colorectal Dis. 2012 ; 14 : 508-14.
PubMed
P.306 掲載の参考文献
1) 出雲周二, 松崎敏男, 久保田龍二. HAMの新しい展開. 神経内科. 2001 ; 75 : 369-73.
 
2) 厚生労働科研費新興・再興感染症研究事業「本邦におけるHTLV-I感染症および関連疾患の実態と総合対策」 (研究代表者 : 山口一成). 平成21年度報告書. 東京 : 厚生労働省 ; 2010.
 
3) Nagasato K, Nakamura T, Shirabe S, et al. Presence of serum anti-human T-lymphotropic virus type I (HTLV-I) IgM antibodies means persistent active replication of HTLV-I in HTLV-I-associated myelopathy. J Neurol Sci. 1991 ; 103 : 203-8.
PubMed
4) Izumo S1, Goto I, Itoyama Y, et al. Interferon-alpha is effective in HTLV-I-associated myelopathy : a multicenter, randomized, double-blind, controlled trial. Neurology. 1996 ; 46 : 1016-21.
 
5) Liu R, Sakakibara R, Odaka T, et al. Mechanism of abdominal massage for difficult defecation in a patient with myelopathy (HAM/TSP). J Neurol. 2005 ; 252 : 1280-2.
 
P.309 掲載の参考文献
1) Mannen T, Iwata M, Toyokura Y, et al. Preservation of a certain motoneurone group of the sacral cord in amyotrophic lateral sclerosis : its clinical significance. J Neurol Neurosurg Psychiatry. 1977 ; 40 : 464-9.
PubMed
2) Pisano P, Miscio G, Mazzuero G, et al. Decreased heart rate variability in amyotrophic lateral sclerosis. Muscle Nerve. 1995 ; 18 : 1225-31.
 
3) Kihara M, Takahashi A, Sugenoya J, et al. Sudomotor dysfunction in amyotrophic lateral sclerosis. Funct Neurol. 1994 ; 9 : 193-7.
PubMed
4) Provinciali L, Cangiotti A, Tulli D, et al. Skin abnormalities and autonomic involvement in the early stage of amyotrophic lateral sclerosis. J Neurol Sci. 1994 ; 126 : 54-61.
PubMed
5) Toepfer M, Schroeder M, Klauser A, et al. Delayed colonic transit times in amyotrophic lateral sclerosis assessed with radio-opaque markers. Eur J Med Res. 1997 ; 2 : 473-6.
PubMed
6) Toepfer M, Folwaczny C, Lochmuller H, et al. Noninvasive 13C-octanoic acid breath test shows delayed gastric emptying in patients with amyotrophic lateral sclerosis. Digestion. 1999 ; 60 : 567-71.
 
7) Toepfer M, Folwaczny C, Klauser A, et al. Gastrointestinal dysfunction in amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 1999 ; 1 : 15-9.
PubMed
8) Baltadzhieva R, Gurevich T, Korczyn AD. Autonomic impairment in amyotrophic lateral sclerosis. Curr Opin Neurol. 2005 ; 18 : 487-93.
PubMed
9) Piccione EA, Sletten DM, Staff NP, et al. Autonomic system and amyotrophic lateral sclerosis. Muscle Nerve. 2015 ; 51 : 676-9.
PubMed
10) Ghoos Y, Maes BD, Geypens BJ, et al. Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test. Gastroenterology. 1993 ; 104 : 1640-7.
PubMed
11) Lefaucheur JP. Needle EMG study of the external anal sphincter : Diagnostic value in the flail leg variant of ALS. Neurophysiol Clin. 2016 ; 46 : 153-5.
PubMed
12) Kihira T, Yoshida S, Yoshimasu F, et al. Involvement of Onuf's nucleus in amyotrophic lateral sclerosis. J Neurol Sci. 1997 ; 147 : 81-8.
PubMed
13) Takeda T, Uchihara T, Nakayama Y, et al. Dendritic retraction, but not atrophy, is consistent in amyotrophic lateral sclerosis-comparison between Onuf's neurons and other sacral motor neurons. Acta Neuropathol Commun. 2014 ; 2 : 11.
 
14) Carvalho M, Schwartz MS, Swash M. Involvement of the external anal sphincter in amyotrophic lateral sclerosis. Muscle Nerve. 1995 ; 18 : 848-53.
PubMed
P.313 掲載の参考文献
1) Sakakibara R, Yamaguchi C, Uchiyama T, et al. Pelvic autonomic dysfunction without paraplegia : a sequel of spinal cord stroke. Eur Neurol. 2008 ; 60 : 97-100.
PubMed
2) 清水潤. 脊髄血管障害. 日本臨床. 1991 ; 49 : 21-2.
Medical*Online
3) 柳務. 脊髄の血管障害. 日本臨床. 1993 ; 51 : 668-73.
Medical*Online
4) 高井啓介. 脊髄動静脈奇形の自然経過と治療予後. Spinal Surgery. 2017 ; 31 : 28-34.
 
5) Sakakibara R, Yamaguchi T, Uchiyama T, et al. Calcium polycarbophil improves constipation in non-traumatic spinal cord disorders. Clin Auton Res. 2006 ; 16 : 289-92.
PubMed
P.314 掲載の参考文献
1) Kanesaka T, Ito S, et al. Intestinal pseudo-obstruction in acute myelitis. Internal Medicine. 2006 ; DOI : 10.2169/internalmedicine. 45.1540.
 
2) Takahashi O, Sakakibara R, Kishi M, et al. Pelvic autonomic dysfunction without tetraparesis : a sequel of rubella-related acute longitudinal myelitis. LUTS. 2009 ; 1 : 103-6.
 
P.324 掲載の参考文献
1) Yarandi SS, Srinivasan S. Diabetic gastrointestinal motility disorders and the role of enteric nervous system : current status and future directions. Neurogastroenterol Motil. 2014 ; 26 : 611-24.
PubMed
2) 水上浩哉, 八木橋操六. 糖尿病性ニューロパチー. Clinical Neuroscience. 2014 ; 32 : 1404-6.
 
3) Horvath VJ, Putz Z, Izbeki F, et al. Diabetes-related dysfunction of the small intestine and the colon : focus on motility. Curr Diab Rep. 2015 ; 15 : 94.
PubMed
4) Zhao J, Gregersen H. Diabetes-induced mechanophysiological changes in the esophagus. Ann N Y Acad Sci. 2016 ; 1380 : 139-54.
PubMed
5) Monreal-Robles R, Remes-Troche JM. Diabetes and the esophagus. Curr Treat Options Gastroenterol. 2017 ; 15 : 475-89.
PubMed
6) Kinekawa F, Kubo F, Matsuda K, et al. Esophageal function worsens with long duration of diabetes. J Gastroenterol. 2008 ; 43 : 338-44.
PubMed
7) Vanormelingen C, Tack J, Andrews CN. Diabetic gastroparesis. Br Med Bull. 2013 ; 105 : 213-30.
PubMed
8) Hasler WL. Gastroparesis. Curr Opin Gastroenterol. 2012 ; 28 : 621-8.
PubMed
9) Marathe CS, Rayner CK, Jones KL, et al. Novel insights into the effects of diabetes on gastric motility. Expert Rev Gastroenterol Hepatol. 2016 ; 10 : 581-93.
PubMed
10) 榊原隆次, 尾高健夫, 服部孝道. 排便機能検査. In : 日本自律神経学会, 編. 自律神経機能検査. 第4版. 東京 : 文光堂 ; 2007. p.322-9.
 
11) 山中義崇, 朝比奈正人. 胃電図検査. In : 日本自律神経学会, 編. 自律神経機能検査. 第5版. 東京 : 文光堂 ; 2015. p.361-4.
 
12) 新井英二, 新井誠人, 横須賀收. 胃排出機能検査. In : 日本自律神経学会, 編. 自律神経機能検査. 第5版. 東京 : 文光堂 ; 2015. p.357-60.
 
13) 本郷道夫, 町田知美, 角田 浩. 嚥下機能検査. In : 日本自律神経学会, 編. 自律神経機能検査. 第5版. 東京 : 文光堂 ; 2015. p.351-6.
 
14) Shin AS, Camilleri M. Diagnostic assessment of diabetic gastroparesis. Diabetes. 2013 ; 62 : 2667-73.
PubMed
15) Muresan C, Surdea Blaga T, Muresan L, et al. Abdominal ultrasound for the evaluation of gastric emptying revisited. J Gastrointestin Liver Dis. 2015 ; 24 : 329-38.
PubMed
16) 下田由香里, 櫻井俊弘, 松井敏幸, 他. 消化管通過時間を用いた糖尿病性胃腸障害の定量的評価. 日本消化器病学会雑誌. 1997 ; 94 : 577-84.
 
17) Matsumoto M, Yoshimura R, Akiho H, et al. Gastric emptying in diabetic patients by the 13C-octanoic acid breath test : role of insulin in gastric motility. J Gastroenterol. 2007 ; 42 : 469-74.
PubMed
18) Bharucha AE, Kudva Y, Basu A, et al. Relationship between glycemic control and gastric emptying in poorly controlled type 2 diabetes. Clin Gastroenterol Hepatol. 2015 ; 13 : 466-76. e1.
 
19) Ron Y, Wainstein J, Leibovitz A, et al. The effect of acarbose on the colonic transit time of elderly long-term care patients with type 2 diabetes mellitus. J Gerontol A Biol Sci Med Sci. 2002 ; 57 : M111-4.
PubMed
20) Thiruppathy K, Bajwa A, Kuan KG, et al. Gut symptoms in diabetics correlate with components of the rectoanal inhibitory reflex, but not with pudendal nerve motor latencies or systemic autonomic neuropathy. J Dig Dis. 2015 ; 16 : 342-9.
PubMed
21) 麻生好正. 糖尿病性自律神経障害の治療-病態も含めて. In : 中村二郎, 荒木栄一, 編. 糖尿病性神経障害-基礎から臨床のすべて. 東京 : 中山書店 ; 2013. p.168-78.
 
P.328 掲載の参考文献
1) 日本神経学会, 監. ギラン・バレー症候群, フィッシャー症候群診療ガイドライン. 東京 : 南江堂 ; 2013.
 
2) Hughes RA, Wijdicks EF, Benson E, et al. Multidisciplinary Consensus Group. Supportive care for patients with Guillain-Barre syndrome. Arch Neurol. 2005 ; 62 : 1194-8.
 
3) de la Torre RG, Moris G, Martinez DP, et al. Guillain-Barre syndrome, tuberculosis and inflammatory bowel disease : a multiple association. Int Arch Med. 2010 Jul 16 ; 3 : 15.
 
4) Gabaldon-Torres L, Jordan M, Osorio-Caicedo P, et al. Autoimmune acute motor sensory axonal polyradiculoneuritis in a case of inflammatory bowel disease. Neurologia. 2015 ; 30 : 586-7.
 
5) Netto AB, Taly AB, Kulkarni GB, et al. Complications in mechanically ventilated patients of Guillain-Barre syndrome and their prognostic value. J Neurosci Rural Pract. 2017 ; 8 : 68-73.
PubMed
6) Burns TM, Lawn ND, Low PA, et al. Adynamic ileus in severe Guillain-Barre syndrome. Muscle Nerve. 2001 ; 24 : 963-5.
PubMed
7) Gazulla Abio J, Benavente Aguilar I. Paraparesis, hyperprolactinemia and adynamic ileus in Guillain-Barre syndrome. Neurologia. 2004 ; 19 : 396-400.
 
8) Sawai S, Sakakibara R, Uchiyama T, et al. Acute motor axonal neuropathy presenting with bowel, bladder, and erectile dysfunction. J Neurol. 2007 ; 254 : 250-2.
PubMed
9) Nowe T, Huttemann K, Engelhorn T, et al. Paralytic ileus as a presenting symptom of Guillain-Barre syndrome. J Neurol. 2008 ; 255 : 756-67.
PubMed
10) Man BL, Fu YP. Intestinal pseudo-obstruction as a presenting symptom of Guillain-Barre syndrome. BMJ Case Rep. 2014 ; 2014. pii : bcr2014205155.
 
11) Sakakibara R, Uchiyama T, Asahina M, et al. Micturition disturbance in acute idiopathic autonomic neuropathy. J Neurol Neurosurg Psychiatry. 2004 ; 75 : 287-91.
PubMed
12) 杵川文彦, 松田和也, 島村美恵子, 他. 神経疾患の治療前後における胃運動機能の変化-胃電図による検討-. Therapeutic Research. 2007 ; 28 : 627-9.
Medical*Online
13) Hong SJ, Choe BH. A case of visceral autonomic neuropathy complicated by Guillain-Barre Syndrome accompanied with cyclic vomiting syndrome-like disorder in a child. Pediatr Gastroenterol Hepatol Nutr. 2015 ; 18 : 128-33.
 
14) Lobrano A, Blanchard K, Abell TL, et al. Postinfectious gastroparesis related to autonomic failure : a case report. Neurogastroenterol Motil. 2006 ; 18 : 162-7.
PubMed
P.331 掲載の参考文献
1) Buss DH, Scharyj M. Herpesvirus infection of the esophagus and other visceral organs in adults. Incidence and clinical significance. Am J Med. 1979 ; 66 : 457-62.
PubMed
2) 伊藤透. ヘルペス食道炎 : 30例についての免疫組織学的研究. 金医大誌. 1986 ; 11 : 69-83.
 
3) Krones E, Petritsch W, Valentin T, et al. Visceral dissemination of herpes zoster with multiple ulcers in the upper gastrointestinal tract of an apparently immunocompetent patient. Endoscopy. 2012 ; 44 Suppl 2 UCTN : E302-3.
 
4) Edelman DA, Antaki F, Basson MD, et al. Ogilvie syndrome and herpes zoster : case report and review of the literature. J Emerg Med. 2010 ; 39 : 696-700.
PubMed
5) Hosoe N, Sakakibara R, Yoshida M, et al. Acute, severe constipation in a 58-year-old Japanese patient. Gut. 2011 ; 60 : 1059-93.
 
6) Nomdedeu JF, Nomdedeu J, Martino R, et al. Ogilvie's syndrome from disseminated varicella-zoster infection and infarcted celiac ganglia. J Clin Gastroenterol. 1995 ; 20 : 157-9.
PubMed
7) Pui JC, Furth EE, Minda J, et al. Demonstration of varicella-zoster virus infection in the muscularis propria and myenteric plexi of the colon in an HIV-positive patient with herpes zoster and small bowel pseudo-obstruction (Ogilvie's syndrome). Am J Gastroenterol. 2001 ; 96 : 1627-30.
 
P.334 掲載の参考文献
1) Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology. Neurology. 1996 ; 46 : 1470.
PubMed
2) Garland EM, Hooper WB, Robertson D. Pure autonomic failure. Handb. Clin Neurol. 2013 ; 117 : 243-57.
PubMed
3) Hague K, Lento P, Morgello S, et al. The distribution of Lewy bodies in pure autonomic failure : autopsy findings and review of the literature. Acta Neuropathol. 1997 ; 94 : 192-6.
PubMed
4) Arai K, Kato N, Kashiwado K, et al. Pure autonomic failure in association with human alpha-synucleinopathy. Neurosci Lett. 2000 ; 296 : 171-3.
PubMed
5) Yamanaka Y, Asahina M, Hiraga A, et al. Over 10 years of isolated autonomic failure preceding dementia and Parkinsonism in 2 patients with Lewy body disease. Mov Disord. 2007 ; 22 : 595-7.
PubMed
6) Klein CM, Vernino S, Lennon VA, et al. The spectrum of autoimmune autonomic neuropathies. Ann Neurol. 2003 ; 53 : 752-8.
PubMed
7) 朝比奈正人. アセチルコリンと神経疾患-100年目の現在地. 純粋自律神経不全症とアセチルコリン 研究史と現況. Brain and Nerve : 神経研究の進歩. 2014 ; 66 : 539-50.
 
8) Kaufmann H, Norcliffe-Kaufmann L, Palma JA, et al. Natural history of pure autonomic failure : A United States prospective cohort. Ann Neurol. 2017 ; 81 : 287-97.
PubMed
9) Shibao C, Okamoto L, Biaggioni I. Pharmacotherapy of autonomic failure. Pharmacol Ther. 2012 ; 134 : 279-86.
PubMed
10) Yamanaka Y, Sakakibara R, Asahina M, et al. Chronic intestinal pseudo-obstruction as the initial feature of pure autonomic failure. J Neurol Neurosurg Psychiatry. 2006 ; 77 : 800.
PubMed
11) Masuda H, Asahina M, Oide T, et al. Antemortem detection of colonic alpha-synuclein pathology in a patient with pure autonomic failure. J Neurol. 2014 ; 261 : 2451-2.
 
12) Shibao C, Gamboa A, Diedrich A, et al. Acarbose, an alpha-glucosidase inhibitor, attenuates postprandial hypotension in autonomic failure. Hypertension. 2007 ; 50 : 54-61.
PubMed
P.339 掲載の参考文献
1) 安藤圭, 川上紀明, 宮坂和良, 他. 腰椎椎間板ヘルニアによる馬尾症候群症例の検討. 東海脊椎外科. 2008 ; 1 : 16-20.
 
2) 横山雄一郎, 和田明人, 飯田泰明, 他. 腰椎椎間板ヘルニアによる急性馬尾症候群症例の検討. 日本脊髄障害医学会雑誌. 2009 ; 22 : 116-7.
 
3) Glickmann S, Kamm MA. Bowel dysfunction in spinal cord injury patients. Lancet. 1996 ; 347 : 1651-3.
 
4) Krogh K, Nielsen J, Djurhuus JC, et al. Colorectal function in patients with spinal cord lesions. Dis Colon Rectum. 1997 ; 40 : 1233-9.
PubMed
5) Menter R, Weitzenkamp D, Cooper D, et al. Bowel management outcomes in individuals with long-term spinal cord injuries. Spinal Cord. 1997 ; 35 : 608-12.
PubMed
6) De Looze D, Van Laere M, De Muynck M, et al. Constipation and other chronic gastrointestinal problems in spinal cord injury patients. Spinal Cord. 1998 ; 36 : 63-6.
PubMed
7) Krogh K, Olsen N, Christensen P, et al. Colorectal transport during defecation in patients with lesions of the sacral spinal cord. Neurogastroenterol Motil. 2003 ; 15 : 25-31.
PubMed
8) Brading AF, Ramalingam T. Mechanisms controlling normal defecation and the potential effects of spinal cord injury. Prog Brain Res. 2006 ; 152 : 345-58.
PubMed
9) Gstaltner K, Rosen H, Hufgard R, et al. Sacral nerve stimulation as an option for the treatment of fecal incontinence in patients suffering from cauda equina syndrome. Spinal Cord. 2008 ; 46 : 644-7.
 
10) George AT, Dudding TC, Gurmany S, et al. Pudendal nerve stimulation for bowel dysfunction in complete cauda equina syndrome. Ann Surg. 2014 ; 259 : 502-7.
PubMed
11) Thomas GP, George AT, Dudding TC, et al. A pilot study of chronic pudendal nerve stimulation for faecal incontinence for those who have failed sacral nerve stimulation. Tech Coloproctol. 2014 ; 18 : 731-7.
PubMed
12) Kim JH, Hong JC, Kim MS, et al. Sacral nerve stimulation for treatment of intractable pain associated with cauda equina syndrome. J Korean Neurosurg Soc. 2010 ; 47 : 473-6.
PubMed
P.345 掲載の参考文献
1) 新外科学体系 腹壁・腹膜・イレウスの外科 II. 東京 : 中山書店 ; 1990. 206-8.
 
2) 松倉三郎. イレウスの臨床. 現代外科学体系 第36巻C, 小腸・結腸 III. 東京 : 中山書店 ; 1971. p.3.
 
3) Cohn I Jr. Intestinal obstruction. In : Berk JE, ed. Bochus Gastroenterology. Vol. 3, 4th ed. Philadelphia : WB Saunders ; 1985. 2056-80.
 
4) 急性腹症診療ガイドライン出版委員会, 編. 急性腹症診療ガイドライン 2015. 東京 : 医学書院 ; 2015.
 
5) 森田隆幸, 中村文彦, 鈴木純, 他. 低位前方切除後の排便機能障害の病態と対策. 消化器外科. 1995 ; 18 : 1503-11.
 
6) 日本大腸肛門病学会, 編. 便失禁診療ガイドライン 2017年版. 東京 : 南江堂 ; 2017.
 
7) Kegel AH. Progressive resistance exercise in the functional restoration of the perineal muscles. Am J Obstet Gynecol. 1948 ; 56 : 238-48.
PubMed
8) Tjandra JJ, Han WR, Goh J, et al. Direct repair vs. overlapping sphincter repair : a randomized, controlled trial. Dis Colon Rectum. 2003 ; 46 : 937-42.
PubMed
9) Matzel KE, Stadelmaier U, Hohenfellner M, et al. Electrical stimulation of sacral spinal nerves for treatment of faecal incontinence. Lancet. 1995 ; 346 : 1124-7.
PubMed
10) Manone PS, Ransley PG, Kiely EM, et al. Preliminary report : the antegrade continence enema. Lancet. 1990 ; 336 : 1217-8.
 
P.347 掲載の参考文献
1) 安東由喜雄. アミロイドーシスの分類. In : 安東由喜雄, 植田光晴, 編. アミロイドーシスのすべて-診療ガイドライン2017とQ&A. 東京 : 医歯薬出版 ; 2017. p.2-8.
 
2) Wixner J, Sundstrom T, Karling P, et al. Outcome of gastric emptying and gastrointestinal symptoms after liver transplantation for hereditary transthyretin amyloidosis. BMC Gastroenterol. 2015 ; 15 : 51.
PubMed
3) Cowan AJ, Skinner M, Seldin DC, et al. Amyloidosis of the gastrointestinal tract : a 13-year, single-center, referral experience. Haematologica. 2013 ; 98 : 141-6.
PubMed
4) Wixner J, Mundayat R, Karayal ON, et al. THAOS : gastrointestinal manifestations of transthyretin amyloidosis- common complications of a rare disease. Orphanet J Rare Dis. 2014 ; 9 : 61.
PubMed
5) Shin SC, Robinson-Papp J. Amyloid neuropathies. Mt Sinai J Med. 2012 ; 79 : 733-48.
PubMed
6) Wixner J, Karling P, Rydh A, et al. Gastric emptying in hereditary transthyretin amyloidosis : the impact of autonomic neuropathy. Neurogastroenterol Motil. 2012 ; 24 : 1111-e568.
PubMed
7) Guirl MJ, Hogenauer C, Santa Ana CA, et al. Rapid intestinal transit as a primary cause of severe chronic diarrhea in patients with amyloidosis. Am J Gastroenterol. 2003 ; 98 : 2219-25.
PubMed
8) Ito T, Sakakibara R, Ito S, et al. Mechanism of constipation in familial amyloid polyneuropathy : a case report. Intern Med. 2006 ; 45 : 1173-5.
PubMed
9) Ueda M, Ando Y. Recent advances in transthyretin amyloidosis therapy. Transl Neurodegener. 2014 ; 3 : 19.
 
P.351 掲載の参考文献
1) Barrett TG, Bundey SE, Macleod AF. Neurodegeneration and diabetes : UK nationwide study of Wolfram (DIDMOAD) syndrome. Lancet. 1995 ; 346 : 1458-63.
PubMed
2) Toppings NB, McMillan JM, Au PYB, et al. Wolfram syndrome : a case report and review of clinical manifestations, genetics pathophysiology, and potential therapies. Case Rep Endocrinol. 2018 ; 2018 : 9412676. doi : 10.1155/2018/9412676. eCollection 2018.
 
3) Ito S, Sakakibara R, Hattori T. Wolfram syndrome presenting marked brain MR imaging abnormalities with few neurologic abnormalities. AJNR Am J Neuroradiol. 2007 ; 28 : 305-6.
PubMed
4) Liu Z, Sakakibara R, Uchiyama T et al. Bowel dysfunction in Wolfram syndrome. Diabetes Care. 2006 ; 29 : 472-3.
PubMed
P.353 掲載の参考文献
1) Bardosi A, Creutzfeldt W, DiMauro S, et al. Myo-, neuro-, gastrointestinal encephalopathy (MNGIE syndrome) due to partial deficiency of cytochrome-c-oxidase. A new mitochondrial multisystem disorder. Acta Neuropathol. 1987 ; 74 : 248-58.
PubMed
2) Nishino I, Spinazzola A, Hirano M. Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science. 1999 ; 283 : 689-92.
PubMed
3) Filosto M, Cotti Piccinelli S, Caria F, et al. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE-MTDPS1). J Clin Med. 2018 ; 7. pii : E389.
 
4) Chang TM, Chi CS, Tsai CR, et al. Paralytic ileus in MELAS with phenotypic features of MNGIE. Pediatr Neurol. 2004 ; 31 : 374-7.
PubMed
5) Granero Castro P, Fernandez Arias S, Moreno Gijon M, et al. Emergency surgery in chronic intestinal pseudo-obstruction due to mitochondrial neurogastrointestinal encephalomyopathy : case reports. Int Arch Med. 2010 ; 3 : 35.
PubMed
6) Zimmer V, Feiden W, Becker G, et al. Absence of the interstitial cell of Cajal network in mitochondrial neurogastrointestinal encephalomyopathy. Neurogastroenterol Motil. 2009 ; 21 : 627-31.
PubMed
7) Nalini A, Gayathri N. Mitochondrial neurogastrointestinal encephalopathy in an Indian family with possible manifesting carriers of heterozygous TYMP mutation. J Neurol Sci. 2011 ; 309 : 131-5.
 
8) Giordano C, d'Amati G. Evaluation of gastrointestinal mtDNA depletion in mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). Methods Mol Biol. 2011 ; 755 : 223-32.
PubMed
9) Perez-Atayde AR. Diagnosis of mitochondrial neurogastrointestinal encephalopathy disease in gastrointestinal biopsies. Hum Pathol. 2013 ; 44 : 1440-6.
PubMed
10) Imperatore N, Tortora R, Gerbino N, et al. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) mimicking refractory celiac disease. Dig Liver Dis. 2017 ; 49 : 1061-2.
PubMed
P.357 掲載の参考文献
1) Suita S, Taguchi T, Ieiri S, et al. Hirschsprung's disease in Japan : analysis of 3852 patients based on a nationwide survey in 30 years. J Pediatric Surg. 2006 ; 40 : 197-202.
 
2) 難病情報センター. ヒルシュスプリング病. http://www.nanbyou.or.jp/entry/4700.
 
3) Espinosa-Medina I, Jevans B, Boismoreau F, et al. Dual origin of enteric neurons in vagal Schwann cell precursors and the sympathetic neural crest. Proc Natl Acad Sci USA. 2017 ; 114 : 11980-5.
PubMed
4) Granstrom A, Amin L, Arnell H, et al. Increased risk of inflammatory bowel disease ina population-based cohort study of patients with Hirschsprung disease. J Pediatric Gstroenterol Nutr. 2017 in press.
 
P.360 掲載の参考文献
1) Lo Cascio CM, Goetze O, Latshang TD, et al. Gastrointestinal dysfunction in patients with duchenne muscular dystrophy. PLoS One. 2016 ; 11 : e0163779.
PubMed
2) Ronnblom A, Forsberg H, Danielsson A. Gastrointestinal symptoms in myotonic dystrophy. Scand J Gastroenterol. 1996 ; 31 : 654-7.
PubMed
3) Modolell I, Mearin F, Baudet JS, et al. Pharyngo- esophageal motility disturbances in patients with myotonic dystrophy. Scand J Gastroenterol. 1999 ; 34 : 878-82.
PubMed
4) Garrett JM, DuBose TD, Jackson JE, et al. Esophageal and pulmonary disturbances in myotonia dystrophica. Arch Intern Med. 1969 ; 123 : 26-32.
PubMed
5) Horowitz M, Maddox A, Maddern GJ, et al. Gastric and esophageal emptying in dystrophia myotonica. Effect of metoclopramide. Gastroenterology. 1987 ; 92 : 570-7.
PubMed
6) Costantini M, Zaninotto G, Anselmino M, et al. Esophageal motor function in patients with myotonic dystrophy. Dig Dis Sci. 1996 ; 41 : 2032-8.
PubMed
7) Ronnblom A, Andersson S, Hellstrom PM, et al. Gastric emptying in myotonic dystrophy. Eur J Clin Invest. 2002 ; 32 : 570-4.
PubMed
8) Bellini M, Alduini P, Costa F, et al. Gastric emptying in myotonic dystrophic patients. Dig Liver Dis. 2002 ; 34 : 484-8.
PubMed
9) Schuman BM, Rinaldo JA, Darnley JD. Visceral changes in myotonic dystrophy. Ann Intern Med. 1965 ; 63 : 793-9.
PubMed
10) Pettengell KE, Spitaels JM, Simjee AE. Dysphagia and dystrophia myotonica. A case report. S Afr Med J. 1985 ; 68 : 113-4.
 
11) Chiu VSW, Englert E. Gastrointestinal disturbances in myotonia dystrophica. Gastroenterology. 1962 ; 42 : 745-6.
 
12) Kemp A. Some metabolic aspects of myotonia dystrophica. Folia Psychiatr Neurol Neurochir Neerl. 1957 ; 60 : 88-95.
PubMed
13) Goldberg HI, Sheft DJ. Esophageal and colon changes in myotonia dystrophica. Gastroenterology. 1972 ; 63 : 134-9.
PubMed
14) Bertrand L. Le Megacolon dans la maladie de Steinert. Rev Neurol. 1949 ; 81 : 480-6.
 
15) Gleeson JA, Swann JC, Hughes DT, et al. Dystrophia myotonica radiological survey. Br J Radiol. 1967 ; 40 : 96-100.
PubMed
16) Kark AE, Greenstein AJ. Sigmoid volvulus in muscular dystrophy. Am J Gastroenterol. 1972 ; 57 : 571-7.
PubMed
17) Kohn NN, Faires JS, Rodman T. Unusual manifestations due to involvement of involuntary muscle in dystrophia myotonica. N Engl J Med. 1964 ; 271 : 1179-83.
PubMed
18) Krain S, Rabinowitz JG. The radiologic features of myotonic dystrophy with presentation of a new finding. Clin Radiol. 1971 ; 22 : 462-5.
PubMed
19) Weiner MJ. Myotonic megacolon in myotonic dystrophy. AJR Am J Roentgenol. 1978 ; 130 : 177-9.
PubMed
20) Yoshida MM, Krishnamurthy S, Wattchow DA, et al. Megacolon in myotonic dystrophy caused by a degenerative neuropathy of the myenteric plexus. Gastroenterology. 1988 ; 95 : 820-7.
PubMed
21) Orndahl G, Kock NG, Sundin T. Smooth muscle activity in myotonic dystrophy. Brain. 1973 ; 96 : 857-60.
PubMed
22) Tieleman AA, van Vliet J, Jansen JB, et al. Gastrointestinal involvement is frequent in myotonic dystrophy type 2. Neuromuscul Disord. 2008 ; 18 : 646-9.
PubMed
23) Schuster MM, Tow DE, Sherbourne DH. Anal sphincter abnormalities characteristic of myotonic dystrophy. Gastroenterology. 1965 ; 49 : 641-8.
PubMed
24) Nowak TV, Johnson CP, Kalbfleisch JH, et al. Highly variable gastric emptying in patients with insulin dependent diabetes mellitus. Gut. 1995 ; 37 : 23-9.
PubMed
25) Herbaut AG, Nogueira MC, Panzer JM, et al. Anorectal incontinence in myotonic dystrophy : a myopathic involvement of pelvic floor muscles. Muscle Nerve. 1992 ; 15 : 1210-1.
PubMed
26) Eckardt VF, Nix W. The anal sphincter in patients with myotonic muscular dystrophy. Gastroenterology. 1991 ; 100 : 424-30.
PubMed
27) Abercrombie JF, Rogers J, Swash M. Faecal incontinence in myotonic dystrophy. J Neurol Neurosurg Psychiatry. 1998 ; 64 : 128-30.
PubMed
28) Lecointe-Besancon I, Leroy F, Devroede G, et al. A comparative study of esophageal and anorectal motility in myotonic dystrophy. Dig Dis Sci. 1999 ; 44 : 1090-9.
PubMed
29) Bujanda L, Lopez de Munain A, Alcon A, et al. The gastrointestinal changes in dystrophia myotonica. Rev Esp Enferm Dig. 1997 ; 89 : 711-4.
 
30) Giglio MC, Luglio G, Tarquini R, et al. Role of prucalopride in treatment of chronic constipation and recurrent functional obstruction in a patient with steinert myotonic dystrophy. J Clin Gastroenterol. 2015 ; 49 : 85-6.
 
31) Pelliccioni G, Scarpino O, Piloni V. Procainamide for faecal incontinence in myotonic dystrophy. J Neurol Neurosurg Psychiatry. 1999 ; 67 : 257-8.
PubMed
32) Pucciani F, Iozzi L, Masi A, et al. Multimodal rehabilitation for faecal incontinence : experience of an Italian centre devoted to faecal disorder rehabilitation. Tech Coloproctol 2003 ; 7 : 139-47 ; discussion 147.
PubMed
33) 神山剛一. 出たか出ないかだけじゃない 一人ひとりに合う在宅での排便コントロール「落ち着いて, 気持ちよく出せる」を目指す工夫. 在宅新療 0→100. 2016 ; 1 : 968-70.
 
P.364 掲載の参考文献
1) Stanghellini V, Cogliandro RF, De Giorgio R, et al. Natural history of intestinal failure induced by chronic idiopathic intestinal pseudo-obstruction. Transplant Proc. 2010 ; 42 : 15-8.
PubMed
2) Ohkubo H, Iida H, Takahashi H, et al. An epidemiologic survey of chronic intestinal pseudo-obstruction and evaluation of the newly proposed diagnostic criteria. Digestion. 2012 ; 86 : 12-9.
PubMed
3) Iida H, Ohkubo H, Inamori M, et al. Epidemiology and clinical experience of chronic intestinal pseudo-obstruction in Japan : A nationwide epidemiologic survey. J Epidemiol. 2013 ; 23 : 288-94.
PubMed
4) Amiot A, Joly F, Alves A, et al. Long-term outcome of chronic pseudo-obstruction adult patients requiring home parenteral nutrition. Am J Gastroenterol. 2009 ; 104 : 1262-70.
PubMed
5) Ohkubo H, Kessoku T, Fuyuki A, et al. Assessment of small bowel motility in patients with chronic intestinal pseudo-obstruction using cine-MRI. Am J Gastroenterol. 2013 ; 108 : 1130-9.
PubMed
6) Fuyuki A, Ohkubo H, Higurashi T, et al. Clinical importance of cine-MRI assessment of small bowel motility in patients with chronic intestinal pseudo-obstruction : a retrospective study of 33 patients. J Gastroenterol. 2017 ; 52 : 577-84.
PubMed
7) Amiot A, Cazals-Hatem D, Joly F, et al. The role of immunohistochemistry in idiopathic chronic intestinal pseudoobstruction (CIPO) : a case-control study. Am J Surg Pathol. 2009 ; 33 : 749-58.
PubMed
8) Knowles CH, De Giorgio R, Kapur RP, et al. The London Classification of gastrointestinal neuromuscular pathology : report on behalf of the Gastro 2009 International Working Group, Gut. 59 : 882-887.
 
9) Lauro A, De Giorgio R, Pinna AD. Advancement in the clinical management of intestinal pseudo-obstruction. Expert Rev Gastroenterol Hepatol. 2015 ; 9 : 197-208.
PubMed
10) Ohkubo H, Fuyuki A, Arimoto J, et al. Efficay of percutaneous endoscopic gastro-jejunostomy (PEG-J) decompression therapy for patients with chronic intestinal pseudo-obstruction (CIPO). Neurogastroenterol Motil. 2017 ; 29 : e13127.
 
11) Masaki T, Sugihara K, Nakajima A, et al. Nationwide survey on adult type chronic intestinal pseudo-obstruction in surgical institutions in Japan. Surg Today. 2012 ; 42 : 264-71.
PubMed
12) 中島淳. 慢性偽性腸閉塞症の診療ガイドChronic Intestinal Pseudo-obstruction (CIPO). 平成23年厚生労働科学研究費補助金難治性疾患克服研究事業 慢性特発性偽性腸閉塞症の我が国における疫学・診断・治療の実態調査研究班, 編. 第1版. 2012.
 
P.369 掲載の参考文献
1) 厚生労働省. 平成25年度国民生活基準調査. p.45.
 
2) Nakanishi N, Tatara K, Naramura H, et al. Urinary and fecal incontinence in acommunity-residing older population in Japan. J Am Geriatr Soc. 1997 ; 45 : 215-9.
 
3) 日本大腸肛門病学会, 編. 便失禁診療ガイドライン 2017年版. 東京 : 南江堂 ; 2017.
 
4) 味村俊樹, 角田明良, 仙石淳, 他. 難治性排便障害に対する経肛門的洗腸療法 前向き多施設共同研究. 日本大腸肛門病学会誌. 2018 ; 71 : 70-85.
 
5) 陶山啓子, 加藤基子, 赤松公子, 他. 介護施設で生活する高齢者の排便障害の実態とその要因. 老年看護学. 2006 ; vol. 10 No. 2 : p.34-40.
 
6) 杉山みち子, 安部真佐子, 有澤正子, 他. 高齢者の消化・吸収. In : 細谷憲政, 監修. 武藤泰敏, 編著. 消化・吸収 基礎と臨床. 改訂新版. 東京 : 第一出版 ; 2003. p.377-86.
 
7) 光岡知足. 人の健康は腸内細菌で決まる. 東京 : 技術評論社 ; 2011. p.41.
 
8) 葛谷雅文. 低栄養. In : 大内尉義, 秋山弘子, 編. 新老年学. 第3版. 東京 : 東京大学出版会 ; 2010. p.579-90.
 
9) 厚生労働省. 高齢者. https://www.mhlw.go.jp/file/05-Shingikai-10901000-Kenkoukyoku-Soumuka/0000042643.pdf
 
10) 長寿科学振興財団. 健康長寿ネット. https://www.tyojyu.or.jp/net/byouki/frailty/shindan.html (2017/12/19)
 
11) 厚生労働省. 日本人の食事摂取基準 2015年版.
 
12) Spiller GA, Chernoff MC, Shipey EA, et al. Can fecal weight be used to establish a recommended intake of dieraly fiber (plantix) ? AM J clin Nutter. 1977 ; 30 ; 659-60.
 
13) 日本大腸肛門病学会, 編. 慢性機能性便失禁診療ガイドライン 2017年版. 東京 : 南江堂 ; 2017. p.50.
 
14) 日本大腸肛門病学会, 編. 慢性機能性便秘診療ガイドライン 2017年版. 東京 : 南江堂 ; 2017. p.60.
 
15) 日本大腸肛門病学会, 編. 慢性機能性便秘診療ガイドライン 2017年版. 東京 : 南江堂 ; 2017. p.61.
 
16) 竹田博幸. 11. プロバイオティクス, シンバイオティクス. In : 古賀泰裕, 編. 医科プロバイオティクス学. 東京 : シナジー ; 2009. p.190.
 
17) Fateh R, Iravani S, Frootan M, et al. Synbiotics preparation in men suffering from functional constipation : a randomized controlled trial. Swiss Med Wkly. 2011 ; 141 : w13239.
PubMed
18) 日本老年医学会. 在宅医療に関するエビデンス : 系統的レビュー. https://www.jpn-geriat-soc.or.jp/info/topics/pdf/20150513_01_01.pd.
 
19) 日本大腸肛門病学会, 編. 慢性機能性便失禁診療ガイドライン 2017年版. 東京 : 南江堂 ; 2017. p.58.
 
20) 木下芳一, 川島耕作, 石原俊治. 治療の総論. In : 中島淳, 編. 臨床医のための慢性便秘マネジメントの必須知識. 東京 : 医薬ジャーナル社 ; 2015. p.110.
 
21) 日本大腸肛門病学会, 編. 慢性機能性便失禁診療ガイドライン 2017年版. 東京 : 南江堂 ; 2017. p.52.
 

書評

最近チェックした商品履歴

Loading...